
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-a68b4900.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-0a3f24ce.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Exploring Phytochemical Adjuvant Therapy in Melanoma Treatment: The Effects of MAZ‐51 and Zingerone on Melanoma Cell Proliferation - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="4DDE442B89B6C8031B442B00469282BC.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="blackwellopen">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12283137/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Clinical and Experimental Pharmacology &amp; Physiology">
<meta name="citation_title" content="Exploring Phytochemical Adjuvant Therapy in Melanoma Treatment: The Effects of MAZ‐51 and Zingerone on Melanoma Cell Proliferation">
<meta name="citation_author" content="Kganya Letsoalo">
<meta name="citation_author_institution" content="Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa">
<meta name="citation_author" content="Charlise Basson">
<meta name="citation_author_institution" content="Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa">
<meta name="citation_author" content="Trevor Nyakudya">
<meta name="citation_author_institution" content="Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa">
<meta name="citation_author" content="Yvette Hlophe">
<meta name="citation_author_institution" content="Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa">
<meta name="citation_publication_date" content="2025 Jul 22">
<meta name="citation_volume" content="52">
<meta name="citation_issue" content="9">
<meta name="citation_firstpage" content="e70059">
<meta name="citation_doi" content="10.1111/1440-1681.70059">
<meta name="citation_pmid" content="40695356">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12283137/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12283137/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12283137/pdf/CEP-52-0.pdf">
<meta name="description" content="Current melanoma treatment results in adverse effects, prompting the use of phytochemicals as adjuvant therapy to reduce the reliance on synthetic drugs and combat drug resistance. This study investigated the in vitro effect of ...">
<meta name="og:title" content="Exploring Phytochemical Adjuvant Therapy in Melanoma Treatment: The Effects of MAZ‐51 and Zingerone on Melanoma Cell Proliferation">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Current melanoma treatment results in adverse effects, prompting the use of phytochemicals as adjuvant therapy to reduce the reliance on synthetic drugs and combat drug resistance. This study investigated the in vitro effect of ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12283137/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-testid="header" data-header >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            
                <a class="ncbi-header__logo-container" href="https://www.ncbi.nlm.nih.gov/">
                    <img alt="
                                  NCBI home page
                              "
                         class="ncbi-header__logo-image"
                         src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg" />
                </a>
            

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                


    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true"    >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                


    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true"    data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-testid="searchPanel"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      aria-describedby="search-field-desktop-navigation-help-text"
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only"
                           data-testid="label"
                           for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           data-testid="textInput"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    data-testid="button"
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  role="search">
                <label class="usa-sr-only" for="search-field">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="search" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
    

    Dashboard

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
    

    Publications

    
</a>

                        </li>
                    
                        <li class="usa-nav__primary-item">
                            








<a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
    

    Account settings

    
</a>

                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        <a class="usa-link" href="https://www.ncbi.nlm.nih.gov/pmc/advanced/" data-ga-action="featured_link" data-ga-label="advanced_search">
                            Advanced Search
                        </a>
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12283137">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1111/1440-1681.70059"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/CEP-52-0.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12283137%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12283137/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12283137/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12283137/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-blackwellopen.png" alt="Wiley Open Access Collection logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Wiley Open Access Collection" title="Link to Wiley Open Access Collection" shape="default" href="https://doi.org/10.1111/1440-1681.70059" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Clin Exp Pharmacol Physiol</button></div>. 2025 Jul 22;52(9):e70059. doi: <a href="https://doi.org/10.1111/1440-1681.70059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1111/1440-1681.70059</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Clin%20Exp%20Pharmacol%20Physiol%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clin%20Exp%20Pharmacol%20Physiol%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Clin%20Exp%20Pharmacol%20Physiol%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Clin%20Exp%20Pharmacol%20Physiol%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Exploring Phytochemical Adjuvant Therapy in Melanoma Treatment: The Effects of MAZ‐51 and Zingerone on Melanoma Cell Proliferation</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Letsoalo%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Kganya Letsoalo</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Kganya Letsoalo</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Letsoalo%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kganya Letsoalo</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Basson%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Charlise Basson</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Charlise Basson</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Basson%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Charlise Basson</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nyakudya%20T%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Trevor Nyakudya</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Trevor Nyakudya</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nyakudya%20T%22%5BAuthor%5D" class="usa-link"><span class="name western">Trevor Nyakudya</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hlophe%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Yvette Hlophe</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Yvette Hlophe</span></h3>
<div class="p">
<sup>
<sup>1</sup>
</sup>Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hlophe%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yvette Hlophe</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="cep70059-aff-0001">
<sup>
<sup>1</sup>
</sup>Department of Physiology, School of Medicine, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa</div>
<div class="author-notes p">
<div class="fn" id="correspondenceTo">
<sup>*</sup><p class="display-inline">

<strong>Correspondence:</strong>
 
Yvette Hlophe (<span>yvette.hlophe@up.ac.za</span>)
</p>
</div>
<div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Revised 2025 Jun 11; Received 2025 Mar 23; Accepted 2025 Jul 8; Issue date 2025 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). <em>Clinical and Experimental Pharmacology and Physiology</em> published by John Wiley &amp; Sons Australia, Ltd.</div>
<p>This is an open access article under the terms of the <a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc/4.0/</a> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12283137  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40695356/" class="usa-link">40695356</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>ABSTRACT</h2>
<p>Current melanoma treatment results in adverse effects, prompting the use of phytochemicals as adjuvant therapy to reduce the reliance on synthetic drugs and combat drug resistance. This study investigated the in vitro effect of (3‐(4‐Dimethylamino‐naphthelen‐1‐ylmethylene)‐1, 3‐hydroindol‐2‐one) (MAZ‐51) and zingerone, a ginger derivative, on melanoma cell proliferation in B16‐F10 melanoma and HaCaT human keratinocyte cell lines. The cells were treated with MAZ‐51 (0.002–0.005 mg/mL) and zingerone (0.5–2 mg/mL) at 24, 48 and 72 h, as well as combined treatment (at IC<sub>50</sub> at 48 and 72 h), to determine cell numbers using a crystal violet assay, which was also utilised to investigate the effects of vascular endothelial growth factor (VEGF) co‐treated medium on cell numbers. Morphological changes were examined using haematoxylin and eosin (H&amp;E) staining and polarisation optical density inferential contrast (PlasDIC) and cell cycle progression using flow cytometry. The B16‐F10 half maximal inhibitory concentrations (IC<sub>50</sub>) were 0.05428, 0.03162 and 0.01204 mg/mL for MAZ‐51 at 24, 48 and 72 h, respectively, and 27.9, 2.199 and 1.219 mg/mL for zingerone at 24, 48 and 72 h respectively. Both compounds reduced cell numbers at 48 and 72 h (<em>p</em> &lt; 0.05) and co‐treatment with VEGF exhibited a decrease in cell numbers. Morphological analysis revealed characteristics of cell death, and flow cytometry analysis exhibited a mitotic block. Our findings demonstrate that individual treatment exhibited significant antiproliferative effects on melanoma cells. However, the combination treatment resulted in a combination index (CI) that is greater than one at IC<sub>50</sub> and IC<sub>25</sub>, indicating antagonism. Therefore, future studies should consider the individual effects of the compounds on melanoma proliferation.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> MAZ‐51 and chemotherapeutics, melanoma, phytochemicals, zingerone</p></section></section><section id="cep70059-sec-0001"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Cancer initiation and progression is a multifaceted process that transforms normal cells into malignant cells [<a href="#cep70059-bib-0001" class="usa-link" aria-describedby="cep70059-bib-0001">1</a>]. According to the International Agency for Research on Cancer (IARC), more than 18.1 million new cases and 9.5 million cancer‐related deaths were recorded in 2020 [<a href="#cep70059-bib-0002" class="usa-link" aria-describedby="cep70059-bib-0002">2</a>]. In addition, the IARC estimates that an additional 29.5 million new cases and 16.4 million cancer‐related deaths will be recorded by 2040 [<a href="#cep70059-bib-0002" class="usa-link" aria-describedby="cep70059-bib-0002">2</a>]. South Africa recorded approximately 108 168 new cases and 56 802 cancer‐related deaths in 2020. Prostate, lung, colon‐rectum cancer, and Kaposi sarcoma are the most prevalent types of cancers among South African males, whereas breast, cervical‐uterine, colorectum, and lung cancers are prominent in South African females [<a href="#cep70059-bib-0002" class="usa-link" aria-describedby="cep70059-bib-0002">2</a>]. Melanoma, an aggressive form of skin cancer, is derived from the neoplastic transformation of melanocytes and is classified into four subgroups, namely: superficial spreading, nodular, lentigo, and acral lentiginous melanoma [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>]. Despite accounting for less than 1% of skin cancer cases, melanoma is responsible for 90% of skin cancer‐related deaths due to its high metastatic potential [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>].</p>
<p>In contrast to normal cells, which respond to exogenous stimuli to regulate growth and metastasis, tumour cells, through the accumulation of genetic mutations, become insensitive to these anti‐mitogenic signals, allowing them to evade the apoptotic and repair mechanisms [<a href="#cep70059-bib-0004" class="usa-link" aria-describedby="cep70059-bib-0004">4</a>]. To establish a metastatic niche, tumour cells, along with tumour‐associated macrophages (TAMs) and stromal cells, secrete various regulatory factors such as growth factors, cytokines, and chemokines that promote a favourable environment for melanoma growth by stimulating the proliferation of lymphatic endothelial cells (LECs), prompting lymphangiogenesis [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>, <a href="#cep70059-bib-0005" class="usa-link" aria-describedby="cep70059-bib-0005">5</a>]. Lymphangiogenesis, the sprouting of lymphatic vasculature from pre‐existing vessels, is primarily driven by vascular endothelial growth factor receptor 3 (VEGFR‐3) and its ligands (VEGF‐C and D) [<a href="#cep70059-bib-0005" class="usa-link" aria-describedby="cep70059-bib-0005">5</a>, <a href="#cep70059-bib-0006" class="usa-link" aria-describedby="cep70059-bib-0006">6</a>]. Activation of the VEGFR‐3 signalling pathway stimulates LEC proliferation and lymphatic vessel remodelling, creating a metastatic route to lymph nodes and secondary locations. The elevated expression of the VEGFR‐3/VEGF‐C axis is a key prognostic factor in multiple cancers, including melanoma, colorectal, lung adenocarcinoma, and breast cancer [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>]. Therefore, targeting this signalling pathway is a potential therapeutic approach for melanoma growth and progression.</p>
<p>Inhibiting the VEGFR‐3 pathway by disrupting the binding of VEGF‐C/D to their receptor may combat lymphangiogenic metastasis and proliferation [<a href="#cep70059-bib-0005" class="usa-link" aria-describedby="cep70059-bib-0005">5</a>]. (3‐(4‐dimethylaminonaphthelen‐1‐ylmethylene)‐1,3‐dihydroindol‐2‐one) MAZ‐51, an indolinone‐based synthetic molecule, prevents receptor tyrosine kinase (RTK) activity of VEGFR‐3 [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>, <a href="#cep70059-bib-0007" class="usa-link" aria-describedby="cep70059-bib-0007">7</a>]. By hindering VEGF‐C induced activation of VEGFR‐3, MAZ‐51 impedes receptor phosphorylation and activation of downstream signalling pathways and thus inhibits lymphangiogenesis and proliferation [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>].</p>
<p>A significant challenge in modern cancer treatment strategies is the development of unintended side‐effects due to traditional cancer drugs, which are cytotoxic to both cancerous and noncancerous cells, leading to common side‐effects such as alopecia, neutropenia, neurological disorders, vomiting, nausea, and increased susceptibility to secondary infections [<a href="#cep70059-bib-0008" class="usa-link" aria-describedby="cep70059-bib-0008">8</a>, <a href="#cep70059-bib-0009" class="usa-link" aria-describedby="cep70059-bib-0009">9</a>]. Additionally, combination therapy often involves using multiple chemotherapeutic agents to target different signalling pathways. However, this approach can lead to multidrug resistance, potentially promoting tumour growth and proliferation [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>]. Additionally, metabolites of anti‐cancer drugs are excreted in wastewater systems, posing an environmental burden [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>].</p>
<p>Given the challenges associated with the use of pharmacological agents in the management of cancer, there is a need to align effective cancer treatment with environmental sustainability by exploring alternative treatment strategies. In light of the accumulating evidence against the use of synthetic drugs due to their unintended side effects, high costs, limited specificity, and toxicity, medicinal plants and their phytochemicals have gained significant attention as alternative potential chemotherapeutic agents [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>, <a href="#cep70059-bib-0010" class="usa-link" aria-describedby="cep70059-bib-0010">10</a>]. Phytochemicals possess antimicrobial, anticancer, and anti‐inflammatory properties, making them promising alternative therapeutics [<a href="#cep70059-bib-0011" class="usa-link" aria-describedby="cep70059-bib-0011">11</a>]. Their low cost, increased accessibility, and limited side effects enhance their suitability compared to synthetic drugs [<a href="#cep70059-bib-0012" class="usa-link" aria-describedby="cep70059-bib-0012">12</a>]. The antiproliferative properties of phytochemicals are attributed to their ability to modulate signalling pathways, promote cell cycle arrest and apoptosis, inactivate carcinogens, inhibit proliferation, and regulate the immune system [<a href="#cep70059-bib-0011" class="usa-link" aria-describedby="cep70059-bib-0011">11</a>, <a href="#cep70059-bib-0013" class="usa-link" aria-describedby="cep70059-bib-0013">13</a>]. Ginger (
<em>Zingiber officinale</em>
) is a medicinal plant that possesses pharmacological properties and elicits its therapeutic effects as a result of its phytochemicals, namely: 6‐gingerol, 6‐shogal and zingerone [<a href="#cep70059-bib-0014" class="usa-link" aria-describedby="cep70059-bib-0014">14</a>].</p>
<p>Zingerone (4‐(4‐hydroxy3‐methoxyphenyl)‐2‐butanone), a bioactive phytochemical compound derived from ginger, exhibits pharmacological properties such as anti‐inflammatory, antidiabetic, antidiarrhoeic, anticancer and antispasmodic properties [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>]. Although limited studies have investigated the effect of zingerone on melanoma cells, its chemotherapeutic properties have been observed in malignancies such as prostate cancer, neuroblastoma, ovarian and colorectal cancer, where it was shown to exhibit antiproliferative properties by inducing cell cycle arrest and inhibiting angiogenesis [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>, <a href="#cep70059-bib-0015" class="usa-link" aria-describedby="cep70059-bib-0015">15</a>, <a href="#cep70059-bib-0016" class="usa-link" aria-describedby="cep70059-bib-0016">16</a>].</p>
<p>Although phytochemicals show promising results as chemotherapeutic agents, their clinical use is limited due to their low bioavailability and the high dose required to achieve significant beneficial effects [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>, <a href="#cep70059-bib-0017" class="usa-link" aria-describedby="cep70059-bib-0017">17</a>, <a href="#cep70059-bib-0018" class="usa-link" aria-describedby="cep70059-bib-0018">18</a>]. However, combining phytochemicals with conventional cytotoxic drugs has gained significant attention. This approach has the potential to reduce the synthetic drug dose, improve drug bioavailability, limit drug resistance and maximise the synergistic effects of phytochemicals with synthetic drugs to inhibit cancer growth and proliferation [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>, <a href="#cep70059-bib-0019" class="usa-link" aria-describedby="cep70059-bib-0019">19</a>].</p>
<p>To our knowledge, limited studies have investigated the effect of combining MAZ‐51 and zingerone on melanoma proliferation. Additionally, these compounds target distinct mechanistic pathways. Therefore, it is beneficial to explore the impact of combination treatment with both compounds to inhibit tumour cell proliferation, as melanoma utilises multiple signalling pathways to promote proliferation and survival and is known to evade attempts to inhibit one signalling pathway by activating another [<a href="#cep70059-bib-0020" class="usa-link" aria-describedby="cep70059-bib-0020">20</a>]. Therefore, this study aimed to investigate the individual and combined effects of MAZ‐51 and zingerone on melanoma cell proliferation using a cell survival assay, microscopy and flow cytometry to identify cell cycle changes.</p></section><section id="cep70059-sec-0002"><h2 class="pmc_sec_title">2. Methodology</h2>
<section id="cep70059-sec-0003"><h3 class="pmc_sec_title">2.1. Ethics approval</h3>
<p>Ethics approval for this study was granted by the University of Pretoria's Faculty of Health Science Research Ethics Committee (Ethics committee number: 192/2022).</p></section><section id="cep70059-sec-0004"><h3 class="pmc_sec_title">2.2. Cell Lines: Melanoma and Keratinocyte Cell Lines</h3>
<p>B16‐F10 melanoma, a highly metastatic cell line, expresses the receptors CXCR4 and VEGFR‐3 and was purchased from the American Type Culture Collection (ATCC CRL‐6475). It is a murine cell line produced as the 10th serial passage subclone of the B16 parent tumour line in the C57BL/6J mice strain [<a href="#cep70059-bib-0021" class="usa-link" aria-describedby="cep70059-bib-0021">21</a>]. The HaCaT cell line is a non‐tumourigenic monoclonal human keratinocyte cell line that is derived from an adult human skin. The cell line exhibits a partially to fully differentiated phenotype. The cell line was purchased from CELLONEX, South Africa and served as a control cell line [<a href="#cep70059-bib-0022" class="usa-link" aria-describedby="cep70059-bib-0022">22</a>]. The B16‐F10 and HaCaT cells were utilised from passages 2–12 and passages 45–55, respectively.</p></section><section id="cep70059-sec-0005"><h3 class="pmc_sec_title">2.3. Sample Preparation</h3>
<p>MAZ‐51 and zingerone were dissolved in dimethyl sulfoxide (DMSO) with a final concentration of less than 0.1% (w/v). Serial dilutions were made by adding ddH<sub>2</sub>O to the compounds. Control samples were treated with a vehicle control of 0.01% DMSO (v/v). An additional control sample at 0.6% DMSO (v/v) and a medium control sample were included following the calculation of the maximal inhibitory concentrations (IC<sub>50</sub>) to account for the increased DMSO concentration for zingerone at IC<sub>50</sub> values. However, nonsignificant differences were recorded between the controls; therefore, 0.01% DMSO was used as the standard control. The concentration ranges utilised in this study were selected from previous literature and were further optimised to yield optimal results for this study [<a href="#cep70059-bib-0015" class="usa-link" aria-describedby="cep70059-bib-0015">15</a>, <a href="#cep70059-bib-0023" class="usa-link" aria-describedby="cep70059-bib-0023">23</a>]. Cells were treated with MAZ‐51 (0.002–0.005 mg/mL), zingerone (0.5–2 mg/mL) and nocodazole (NOC) at 0.004 mg/mL for 24, 48 and 72 h. Nocodazole served as a positive control, as it is known to result in a G<sub>2</sub>/M mitotic phase block [<a href="#cep70059-bib-0024" class="usa-link" aria-describedby="cep70059-bib-0024">24</a>]. Following the determination of the IC<sub>50</sub> values, subsequent experimental assays were performed at 48 and 72 h due to nonsignificant data observed at 24 h. Cells were treated with IC<sub>50</sub> values of MAZ‐51, zingerone, and a combination of MAZ‐51 and zingerone.</p></section><section id="cep70059-sec-0006"><h3 class="pmc_sec_title">2.4. Cell Culture</h3>
<p>The cells were grown in T25 or T75cm<sup>2</sup> culture flasks and were maintained in Dulbecco's modified Eagle's medium (DMEM) (Whitehead Scientific, Brackenfell, Cape Town, South Africa), supplemented with 10% heat‐inactivated foetal calf serum (FCS) and 1% penicillin/streptomycin to form complete culture medium (CCM). Cells were then stored in a humidified Forma Scientific water‐jacketed incubator at 37°C and 5% CO<sub>2</sub>. Cell growth was monitored daily, with CCM changes taking place every 2–3 days.</p>
<p>After reaching 70%–90% confluency, the B16‐F10 and HaCaT cells were sub‐cultured by removing the medium, gently washed twice with 3 mL of 1 × phosphate buffered saline (PBS) and a dissociation agent, namely TrypLE Express phenol red, and 5% trypsin was utilised to aid B16‐F10 and HaCaT cell detachment respectively. This was followed by incubation for 3–5 min. Thereafter, 5 mL of CCM was added to the cell suspension to inactivate the TrypLE Express phenol red and 5% trypsin. The cell suspension was transferred to a 15 mL tube and centrifuged for 5 min at 1429 × <em>g</em>. Following centrifugation, the supernatant was discarded, followed by resuspension with 1 mL of CCM.</p></section><section id="cep70059-sec-0007"><h3 class="pmc_sec_title">2.5. Spectrophotometry</h3>
<section id="cep70059-sec-0008"><h4 class="pmc_sec_title">2.5.1. Determination of Cell Viability: Crystal Violet</h4>
<p>B16‐F10 and HaCaT cells were seeded at a volume of 0.09 mL and concentrations of 5 × 10<sup>4</sup> cells/mL (5 × 10<sup>3</sup> cells/well) and 10 × 10<sup>4</sup> cells/mL (9 × 10<sup>3</sup> cells/well) respectively in 96‐well plates and allowed to attach overnight. Cells were treated with the compounds: zingerone (0.5–2 mg/mL), MAZ‐51 (0.002–0.005 mg/mL) and NOC, a positive control, at 0.004 mg/mL, followed by incubation for 24, 48 and 72 h. Following incubation, termination was aided by the addition of 200 μL of 1% glutaraldehyde dissolved in ddH<sub>2</sub>O to the 96 well plates. The plates were incubated for 30 min followed by the removal of glutaraldehyde. Crystal violet, 100 μL of 0.1% solution, was dissolved in ddH<sub>2</sub>O and added to stain the plates for 30 min at room temperature (RT) followed by rinsing of the plates under running water. The plate was left to dry overnight followed by the addition of 100 μL of 10% acetic acid dissolved in ddH<sub>2</sub>O to solubilise the crystal violet dye. The absorbance was read at 630 nm using a spectrophotometer ELx800 Universal Microplate Reader (Bio‐Tek Instruments Inc.) The results were reported as a percentage of cell viability against the vehicle control group.</p></section></section><section id="cep70059-sec-0009"><h3 class="pmc_sec_title">2.6. Combination Index Calculation</h3>
<p>The following combination index (CI) formula was utilised to determine whether the combination treatment of MAZ‐51 and zingerone resulted in a synergistic, antagonistic, or additive effect. A CI that is greater than, less than, or equal to one indicates an antagonistic, synergistic, or additive effect respectively [<a href="#cep70059-bib-0025" class="usa-link" aria-describedby="cep70059-bib-0025">25</a>].</p>
<table class="disp-formula p" id="cep70059-disp-0001"><tr><td class="formula"><math id="jats-math-1" display="block" overflow="linebreak"><mrow><mrow><mi>CI</mi><mo linebreak="goodbreak">=</mo><msub><mi mathvariant="normal">C</mi><mrow><mi mathvariant="normal">A</mi><mo>,</mo><mi mathvariant="normal">x</mi></mrow></msub><mo>/</mo><msub><mi>IC</mi><mi mathvariant="normal">A</mi></msub><mo linebreak="goodbreak">+</mo><msub><mi mathvariant="normal">C</mi><mrow><mi mathvariant="normal">B</mi><mo>,</mo><mi mathvariant="normal">x</mi></mrow></msub><mo>/</mo><msub><mi>IC</mi><mi mathvariant="normal">B</mi></msub></mrow></mrow></math></td></tr></table>
<p>where C<sub>A,x</sub> is the concentration of compound A at which a cytotoxic effect is observed and IC<sub>A</sub> is the IC<sub>50</sub> of compound A. C<sub>B,x</sub> is the concentration of compound B at which a cytotoxic effect is observed and IC<sub>B</sub> is the IC<sub>50</sub> of compound B. If the CI is equal to 1, there is an additive effect; if the CI is above 1, there is an antagonistic effect; and if CI is below 1, there is a synergistic effect [<a href="#cep70059-bib-0025" class="usa-link" aria-describedby="cep70059-bib-0025">25</a>].</p></section><section id="cep70059-sec-0010"><h3 class="pmc_sec_title">2.7. Determination of Cell Morphology</h3>
<section id="cep70059-sec-0011"><h4 class="pmc_sec_title">2.7.1. Polarisation Optical Differential Inferential Contrast and Haematoxylin and Eosin Staining</h4>
<p>The cells were seeded on heat‐sterilised coverslips in a 24‐well plate at a volume of 0.45 mL and concentrations of 10 × 10<sup>4</sup> cells/mL (4.5 × 10<sup>4</sup> cells/well) and 20 × 10<sup>4</sup> cells/mL (9 × 10<sup>4</sup> cells/well) for the B16‐F10 and HaCaT cells respectively and were left to attach overnight. Following overnight incubation, cells were exposed to the different compounds: NOC, MAZ‐51, zingerone and a combination of MAZ‐51 and zingerone at the calculated B16‐F10 IC<sub>50</sub> values for 48 and 72 h. For PlasDIC, images were taken using the Zeiss inverted microscope (Axiovert CFL40 Zeiss; Oberkochen, Germany). Following PlasDIC, the CCM was removed, and the cells were fixed with Bouin's fixative for an hour. Bouin's fixative was removed, and 70% ethanol was added to the coverslips for 20 min at RT. Coverslips were then rinsed for 2 min with tap water followed by the addition of Mayer's haematoxylin for 20 min and rinsing under tap water for 2 min. Coverslips were treated with 70% ethanol followed by the addition of 1% eosin dissolved in ddH<sub>2</sub>O for 5 min. The eosin was removed, and the coverslips were dehydrated twice with increasing concentrations of ethanol at 70%, 96% and 100% followed by the addition of xylene. Coverslips were mounted on microscope slides with resin and were left to dry. Zeiss Axiovert MRc microscope (Zeiss, Oberkochen, Germany) was used to acquire images at 100 × magnification with immersion oil.</p></section></section><section id="cep70059-sec-0012"><h3 class="pmc_sec_title">2.8. Flow Cytometry</h3>
<section id="cep70059-sec-0013"><h4 class="pmc_sec_title">2.8.1. Cell Cycle Analysis</h4>
<p>B16‐F10 and HaCaT cells were seeded in a 24‐well plate at a volume of 0.45 mL and concentrations of 10 × 10<sup>4</sup> cells/mL (4.5 × 10<sup>4</sup> cells/well) and 20 × 10<sup>4</sup> cells/mL (9 × 10<sup>4</sup> cells/well) respectively, and allowed to attach overnight. Cells were treated with NOC, zingerone, MAZ‐51, and a combination of zingerone and MAZ‐51 at the B16‐F10 IC<sub>50</sub> values for 48 and 72 h, followed by trypsinisation and resuspension in 1 mL of CCM. The cells were centrifuged for 5 min at 1429 × g, followed by resuspension of the pellet with 200 μL ice‐cold PBS. The cells were centrifuged for 5 min, and the supernatant was discarded. Cells were treated with 70% methanol that was added in a drop‐wise manner and stored at −20°C before analysis took place. Prior to analysis, cells were pelleted by centrifuging them for 5 min at 1429 × <em>g</em>. The supernatant was removed, followed by washing the cells in a 0.5% bovine serum albumin (BSA)/PBS solution. Cells were resuspended in 1 mL of PBS that contains propidium iodide (PI) (40 μg/mL), 100 μg/mL RNase A and 0.1% triton‐X, and incubated at 37°C, 5% CO<sub>2</sub> for 45 min. An FC500 flow cytometer (Beckman Coulter, Johannesburg, South Africa) was used for cell analysis. Distribution of the cell cycle was calculated using Kaluza C software (version 1.2.1) by allocating deoxyribonucleic acid (DNA) content per cell to sub‐G<sub>1</sub>, G<sub>1</sub>, S and G<sub>2</sub>/M phases.</p></section></section><section id="cep70059-sec-0014"><h3 class="pmc_sec_title">2.9. The Effect of a Growth Factor on Cell Numbers</h3>
<section id="cep70059-sec-0015"><h4 class="pmc_sec_title">2.9.1. Vascular Endothelial Growth Factor</h4>
<p>B16‐F10 and HaCaT cells were seeded at a volume of 0.09 mL and concentrations of 5 × 10<sup>4</sup> cells/mL (5 × 10<sup>3</sup> cells/well) and 10 x 10<sup>4</sup> cells/mL (9 × 10<sup>3</sup> cells/well) respectively, in a 96‐well plate. Cells were exposed to MAZ‐51, zingerone, and a combination of MAZ‐51 and zingerone at the B16‐F10 IC<sub>50</sub>. Cells were further exposed to either 20 or 60 ng/mL of vascular endothelial growth factor (VEGF) (Sigma‐Aldrich, Kempton Park, South Africa) for the stipulated time period of 48–72 h. Additional control samples were included, either exposed to VEGF or not exposed to VEGF at 20 or 60 ng/mL. Crystal violet analysis was then carried out in the same manner as explained in Section <a href="#cep70059-sec-0008" class="usa-link">2.5.1</a>.</p></section></section><section id="cep70059-sec-0016"><h3 class="pmc_sec_title">2.10. Statistical Analysis</h3>
<p>Each experiment was performed with three technical and three biological repeats for all cell lines and was tested for normality using the Shapiro–Wilk test. Data obtained from quantitative experiments are represented by the mean ± standard error of the mean (SEM) and statistically analysed using the one‐way analysis of variance (ANOVA). The Bonferroni test was used as a post hoc test for all pairwise analyses and <em>p</em> ≤ 0.05 was considered statistically significant. GraphPad Prism version 9.5.1 was utilised for statistical analysis.</p></section></section><section id="cep70059-sec-0017"><h2 class="pmc_sec_title">3. Results</h2>
<section id="cep70059-sec-0018"><h3 class="pmc_sec_title">3.1. Crystal Violet Staining of B16‐F10 and HaCaT Cells: Zingerone and MAZ‐51 Induced a Decrease in Cell Viability</h3>
<p>The effects of the compounds MAZ‐51 and zingerone at concentration ranges of 0.002–0.005 and 0.5–2 mg/mL, respectively were evaluated on the B16‐F10 melanoma and HaCaT human keratinocyte cell lines for viability for 24, 48 and 72 h.</p>
<p>Zingerone‐treated B16‐F10 cells significantly decreased cell numbers from concentrations of 1.5–2 and 0.5–2 mg/mL for 48 and 72 h, respectively (<em>p</em> &lt; 0.05; Figure <a href="#cep70059-fig-0001" class="usa-link">1A</a>) whereas HaCaT cells displayed a significant decrease in cell numbers at concentrations of 1–2 mg/mL at 24, 48, and 72 h (<em>p</em> &lt; 0.05; Figure <a href="#cep70059-fig-0001" class="usa-link">1C</a>). A significant decrease in cell numbers was also observed in MAZ‐51 treated B16‐F10 cells from 0.004 and 0.005 mg/mL at 72 h (<em>p</em> &lt; 0.05; Figure <a href="#cep70059-fig-0001" class="usa-link">1B</a>). However, a nonsignificant decrease was observed in MAZ‐51 treated HaCaT cells at 24, 48, and 72 h (Figure <a href="#cep70059-fig-0001" class="usa-link">1D</a>).</p>
<figure class="fig xbox font-sm" id="cep70059-fig-0001"><h4 class="obj_head">FIGURE 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b3/12283137/f2a9eb11177c/CEP-52-0-g007.jpg" loading="lazy" id="jats-graphic-1" height="474" width="709" alt="FIGURE 1"></p>
<div class="p text-right font-secondary"><a href="figure/cep70059-fig-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The effect of zingerone and MAZ‐51 on the cell number of the B16‐F10 (A, B) and HaCaT (C, D) cells at 24, 48, and 72 h. *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ****<em>p</em> &lt; 0.0001 indicates significance in comparison to the control. Graphs were designed using GraphPad Prism version 9.5.1.</p></figcaption></figure><p>The positive control, NOC, induced a significant decrease in cell numbers in the B16‐F10 cells at 48 and 72 h (<em>p</em> &lt; 0.01; Figure <a href="#cep70059-fig-0001" class="usa-link">1A</a>) whereas a significant decrease at 24, 48, and 72 h was observed in the HaCaT cells (<em>p</em> &lt; 0.05; Figure <a href="#cep70059-fig-0001" class="usa-link">1C,D</a>).</p>
<p>The IC<sub>50</sub> determined by linear regression for zingerone was 27.9, 2.199 and 1.219 mg/mL at 24, 48 and 72 h, respectively. The IC<sub>50</sub> for MAZ‐51 was 0.05428, 0.03162 and 0.01204 mg/mL at 24, 48 and 72 h, respectively (Table <a href="#cep70059-tbl-0001" class="usa-link">1</a>). Due to the non‐statistical decrease in cell numbers observed at 24 h, subsequent experimental assays were conducted at 48 and 72 h. The IC<sub>50</sub> values resulted in lower percentage cell numbers in the B16‐F10 cell lines in comparison to the HaCaT cells at 48 h (Figure <a href="#cep70059-fig-0002" class="usa-link">2</a>). However, at 72 h treatment with zingerone at IC<sub>50</sub> and a combination of MAZ‐51 and zingerone was more potent in the control cell lines compared to the B16‐F10 cell lines (Figure <a href="#cep70059-fig-0002" class="usa-link">2</a>). The combination treatments at IC<sub>50</sub> resulted in a CI of 2 for both 48 and 72 h (Figure <a href="#cep70059-fig-0003" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="cep70059-tbl-0001"><h4 class="obj_head">TABLE 1.</h4>
<div class="caption p"><p>Table depicting the half maximal inhibitory concentrations (mg/mL) for the B16‐F10 and HaCaT cell lines at 24, 48, and 72 h.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" valign="bottom" colspan="1"></th>
<th align="center" colspan="3" valign="bottom" rowspan="1">B16‐F10</th>
<th align="center" colspan="3" valign="bottom" rowspan="1">HaCaTs</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" valign="bottom" rowspan="1" colspan="1">24 h</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">48 h</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">72 h</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">24 h</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">48 h</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">72 h</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">MAZ‐51</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.05428</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.03162</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.01204</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.131E+51</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.557E+46</td>
<td align="center" valign="top" rowspan="1" colspan="1">0.0176</td>
</tr>
<tr>
<td align="left" valign="top" rowspan="1" colspan="1">Zingerone</td>
<td align="center" valign="top" rowspan="1" colspan="1">27.9</td>
<td align="center" valign="top" rowspan="1" colspan="1">2.199</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.219</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.548</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.074</td>
<td align="center" valign="top" rowspan="1" colspan="1">1.027</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cep70059-tbl-0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><figure class="fig xbox font-sm" id="cep70059-fig-0002"><h4 class="obj_head">FIGURE 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b3/12283137/e3d072fe3193/CEP-52-0-g001.jpg" loading="lazy" id="jats-graphic-3" height="281" width="709" alt="FIGURE 2"></p>
<div class="p text-right font-secondary"><a href="figure/cep70059-fig-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The effect of the half maximal inhibitory concentrations of MAZ‐51 and zingerone on the B16‐F10 and HaCaT cells at 48 and 72 h. *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ****<em>p</em> &lt; 0.0001 indicates significance in comparison to the control. Graphs were designed using GraphPad Prism version 9.5.1.</p></figcaption></figure><figure class="fig xbox font-sm" id="cep70059-fig-0003"><h4 class="obj_head">FIGURE 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b3/12283137/8ecbb2331f57/CEP-52-0-g005.jpg" loading="lazy" id="jats-graphic-5" height="352" width="661" alt="FIGURE 3"></p>
<div class="p text-right font-secondary"><a href="figure/cep70059-fig-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Combination index (CI) recorded at 48 and 72 h for treatment with MAZ‐51 (IC<sub>50</sub>) + zingerone (IC<sub>50</sub>) and MAZ‐51 (IC<sub>50</sub>) + zingerone (IC<sub>25</sub>). A CI &gt; 1 indicates antagonism between the two compounds. The CI was calculated using the B16‐F10 melanoma cell's IC<sub>50</sub>. Graph was designed using GraphPad Prism version 9.5.1.</p></figcaption></figure><p>Due to the significant reduction in cell numbers observed in zingerone‐treated HaCaT cells at IC<sub>50</sub> values, the effects of zingerone at IC<sub>25</sub> values (1.0995 mg/mL for 48 h and 0.60695 mg/mL for 72 h) were further investigated. This study also examined the combined treatment of MAZ‐51 at IC<sub>50</sub> and zingerone at IC<sub>25</sub> concentrations in the B16‐F10 and HaCaT cells. In comparison to the IC<sub>50</sub> values, zingerone at IC<sub>25</sub> values resulted in higher percentage cell numbers at both cell lines at 48 and 72 h (<em>p</em> &lt; 0.05; Table <a href="#cep70059-tbl-0002" class="usa-link">2</a>). In addition, combination treatment also resulted in an increase in the percentage cell numbers (<em>p</em> &lt; 0.05; Table <a href="#cep70059-tbl-0002" class="usa-link">2</a>) and CI of 1.5 for 48 and 72 h (Figure <a href="#cep70059-fig-0003" class="usa-link">3</a>).</p>
<section class="tw xbox font-sm" id="cep70059-tbl-0002"><h4 class="obj_head">TABLE 2.</h4>
<div class="caption p"><p>Table comparing the effects of zingerone at IC<sub>50</sub>, IC<sub>25</sub>, and combination treatment on percentage cell numbers on the B16‐F10 and HaCaT cell lines at 48 and 72 h.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" colspan="2" valign="bottom"></th>
<th align="center" colspan="4" valign="bottom" rowspan="1">Treatment compounds</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" colspan="2" valign="bottom" rowspan="1">Zingerone</th>
<th align="center" colspan="2" valign="bottom" rowspan="1">MAZ‐51 + zingerone</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Timelines</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Cell lines</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Zn‐IC<sub>50</sub>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Zn‐IC<sub>25</sub>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">MAZ‐51 IC<sub>50</sub> + Zn IC<sub>50</sub>
</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">MAZ‐51 IC<sub>50</sub> + Zn IC<sub>25</sub>
</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">48 h</td>
<td align="center" valign="top" rowspan="1" colspan="1">B16‐F10</td>
<td align="center" valign="top" rowspan="1" colspan="1">34%**** (27.91–39.80)</td>
<td align="center" valign="top" rowspan="1" colspan="1">47%**** (25.10–65.03)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30%**** (14.20–45.12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">46%**** (19.75–67.89)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">HaCaTs</td>
<td align="center" valign="top" rowspan="1" colspan="1">50%*** (17.03–84.24)</td>
<td align="center" valign="top" rowspan="1" colspan="1">51%** (18.06–104.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">39%**** (29.93–47.34)</td>
<td align="center" valign="top" rowspan="1" colspan="1">52%** (34.46–90.98)</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">72 h</td>
<td align="center" valign="top" rowspan="1" colspan="1">B16‐F10</td>
<td align="center" valign="top" rowspan="1" colspan="1">49%**** (21.56–76.41)</td>
<td align="center" valign="top" rowspan="1" colspan="1">53%**** (22.70–74.61)</td>
<td align="center" valign="top" rowspan="1" colspan="1">41%**** (34.57–46.60)</td>
<td align="center" valign="top" rowspan="1" colspan="1">60%*** (25.86–84.66)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">HaCaTs</td>
<td align="center" valign="top" rowspan="1" colspan="1">28%**** (12.66–42.63)</td>
<td align="center" valign="top" rowspan="1" colspan="1">61%** (52.46–93.36)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28%**** (18.53–37.64)</td>
<td align="center" valign="top" rowspan="1" colspan="1">61%** (51.99–92.57)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cep70059-tbl-0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="cep70059-note-0002"><p>
<em>Note:</em> The confidence intervals are indicated in the brackets. *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ****<em>p</em> &lt; 0.0001 indicates significance in comparison to the control.</p></div></div></section></section><section id="cep70059-sec-0019"><h3 class="pmc_sec_title">3.2. Combination Index Calculation for MAZ‐51 and Zingerone</h3>
<p>This study calculated the CI for MAZ‐51 and zingerone by utilising the concentrations at which the compounds inhibited 50% cell growth, which is tabulated on page 10 Table <a href="#cep70059-tbl-0001" class="usa-link">1</a>. Zingerone's IC<sub>25</sub> values are tabulated in Table <a href="#cep70059-tbl-0002" class="usa-link">2</a>.</p>
<p>
<em>Combination Index Calculation for MAZ‐51 at</em>

<em>IC</em>
<sub>
<em>50</em>
</sub>

<em>and zingerone at</em>

<em>IC</em>
<sub>
<em>50</em>
</sub>

</p>
<p>CI at 48 h = 0.03162 mg/mL/0.03162 mg/mL + 2.199 mg/mL/2.199 mg/mL = 2.</p>
<p>CI at 72 h = 0.01204 mg/mL 0.01204 mg/mL + 1.219 mg/mL/1.219 mg/mL = 2.</p>
<p>
<em>Combination index calculation for MAZ‐51 at</em>

<em>IC</em>
<sub>
<em>50</em>
</sub>

<em>and zingerone at</em>

<em>IC</em>
<sub>
<em>25</em>
</sub>

</p>
<p>CI at 48 h = 0.03162 mg/mL/0.03162 mg/mL + 1.0995 mg/mL/2.199 mg/mL = 1.5.</p>
<p>CI at 72 h = 0.01204 mg/mL/0.01204 mg/mL + 0.6095 mg/mL/1.219 mg/mL = 1.5.</p></section><section id="cep70059-sec-0020"><h3 class="pmc_sec_title">3.3. The Effect of Zingerone and MAZ‐51 on Cell Morphology</h3>
<section id="cep70059-sec-0021"><h4 class="pmc_sec_title">3.3.1. Polarisation Optical Differential Inferential Contrast Imaging of B16‐F10 and HaCaT Cells Treated With Zingerone and MAZ‐51</h4>
<p>In PlasDIC micrographs, B16‐F10 melanoma cells treated with zingerone at IC<sub>50</sub> values at 48 and 72 h exhibited apoptotic bodies and protrusions (Figures <a href="#cep70059-fig-0004" class="usa-link">4</a> and <a href="#cep70059-fig-0005" class="usa-link">5</a>). Samples treated with MAZ‐51 exhibited a decrease in density and cell rounding (Figures <a href="#cep70059-fig-0004" class="usa-link">4</a> and <a href="#cep70059-fig-0005" class="usa-link">5</a>). Combination treatment at IC<sub>50</sub> with MAZ‐51 and zingerone resulted in apoptotic bodies and protrusions (Figures <a href="#cep70059-fig-0004" class="usa-link">4</a> and <a href="#cep70059-fig-0005" class="usa-link">5</a>). NOC‐treated samples revealed cell debris, cell swelling, and a decrease in density (Figures <a href="#cep70059-fig-0004" class="usa-link">4</a> and <a href="#cep70059-fig-0005" class="usa-link">5</a>).</p>
<figure class="fig xbox font-sm" id="cep70059-fig-0004"><h5 class="obj_head">FIGURE 4.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b3/12283137/021c972917ee/CEP-52-0-g002.jpg" loading="lazy" id="jats-graphic-7" height="260" width="709" alt="FIGURE 4"></p>
<div class="p text-right font-secondary"><a href="figure/cep70059-fig-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Polarisation optical differential inferential contrast imaging of B16‐F10 and HaCaT cells at 48 h. Images were taken at 40× magnification. Scale bar 50 μm.</p></figcaption></figure><figure class="fig xbox font-sm" id="cep70059-fig-0005"><h5 class="obj_head">FIGURE 5.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b3/12283137/bd757150373f/CEP-52-0-g006.jpg" loading="lazy" id="jats-graphic-9" height="264" width="709" alt="FIGURE 5"></p>
<div class="p text-right font-secondary"><a href="figure/cep70059-fig-0005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Polarisation optical differential inferential contrast imaging of B16‐F10 and HaCaT cells at 72 h. Images were taken at 40× magnification. Scale bar 50 μm.</p></figcaption></figure><p>HaCaT cells treated with zingerone at IC<sub>50</sub> at 48 and 72 h showed protrusions, whereas exposure to MAZ‐51 led to the development of cell rounding and cell swelling (Figures <a href="#cep70059-fig-0004" class="usa-link">4</a> and <a href="#cep70059-fig-0005" class="usa-link">5</a>). Combination treatment at IC<sub>50</sub> resulted in protrusions. NOC‐treated cells revealed cell swelling and debris (Figures <a href="#cep70059-fig-0004" class="usa-link">4</a> and <a href="#cep70059-fig-0005" class="usa-link">5</a>).</p></section><section id="cep70059-sec-0022"><h4 class="pmc_sec_title">3.3.2. Haematoxylin and Eosin Staining of B16‐F10 and HaCaT Cells Treated With Zingerone and MAZ‐51</h4>
<p>H&amp;E‐stained control B16‐F10 melanoma cells exhibited confluent cells (Figures <a href="#cep70059-fig-0006" class="usa-link">6</a> and <a href="#cep70059-fig-0007" class="usa-link">7</a>). Treatment with zingerone revealed protrusions and apoptotic bodies (Figures <a href="#cep70059-fig-0006" class="usa-link">6</a> and <a href="#cep70059-fig-0007" class="usa-link">7</a>). MAZ‐51‐treated cells exhibited pyknosis, cell swelling, and a decrease in density (Figures <a href="#cep70059-fig-0006" class="usa-link">6</a> and <a href="#cep70059-fig-0007" class="usa-link">7</a>). Combination treatment showed a decrease in density, protrusions, and cell swelling (Figures <a href="#cep70059-fig-0006" class="usa-link">6</a> and <a href="#cep70059-fig-0007" class="usa-link">7</a>). NOC‐treated samples resulted in cell swelling, membrane blebbing, and karyorrhexis (Figures <a href="#cep70059-fig-0006" class="usa-link">6</a> and <a href="#cep70059-fig-0007" class="usa-link">7</a>).</p>
<figure class="fig xbox font-sm" id="cep70059-fig-0006"><h5 class="obj_head">FIGURE 6.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b3/12283137/5e8c31d645b5/CEP-52-0-g004.jpg" loading="lazy" id="jats-graphic-11" height="262" width="709" alt="FIGURE 6"></p>
<div class="p text-right font-secondary"><a href="figure/cep70059-fig-0006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Haematoxylin and eosin staining of B16‐F10 and HaCaT cells at 48 h. Images were taken at 100× magnification. Scale bar 20 μm.</p></figcaption></figure><figure class="fig xbox font-sm" id="cep70059-fig-0007"><h5 class="obj_head">FIGURE 7.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b3/12283137/ece313c1c9d3/CEP-52-0-g008.jpg" loading="lazy" id="jats-graphic-13" height="261" width="709" alt="FIGURE 7"></p>
<div class="p text-right font-secondary"><a href="figure/cep70059-fig-0007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Haematoxylin and eosin staining of B16‐F10 and HaCaT cells at 72 h. Images were taken at 100× magnification. Scale bar 20 μm.</p></figcaption></figure><p>H&amp;E‐stained HaCaT control cells at 48 and 72 h exhibit confluent cells (Figures <a href="#cep70059-fig-0006" class="usa-link">6</a> and <a href="#cep70059-fig-0007" class="usa-link">7</a>). Cells treated with zingerone and a combination of zingerone and MAZ‐51 exhibited protrusions. MAZ‐51 treated cells resulted in karyorrhexis (Figures <a href="#cep70059-fig-0006" class="usa-link">6</a> and <a href="#cep70059-fig-0007" class="usa-link">7</a>). NOC‐treated cells revealed a decrease in density, cell swelling, membrane blebbing, and karyorrhexis (Figures <a href="#cep70059-fig-0006" class="usa-link">6</a> and <a href="#cep70059-fig-0007" class="usa-link">7</a>).</p></section></section><section id="cep70059-sec-0023"><h3 class="pmc_sec_title">3.4. Cell Cycle Analysis of B16‐F10 and HaCaT Cells</h3>
<section id="cep70059-sec-0024"><h4 class="pmc_sec_title">3.4.1. 
MAZ‐51 and Zingerone Resulted in a Cell Cycle Arrest</h4>
<p>Cell cycle analysis showed that there was a significant increase in the number of cells in the sub‐G<sub>1</sub> phase in the B16‐F10 cells treated with MAZ‐51, zingerone, a combination of zingerone and MAZ‐51 at IC<sub>50</sub> and NOC at 48 h. This was followed by a decrease in the number of cells in the G<sub>1</sub> phase (<em>p</em> &lt; 0.05; Figure <a href="#cep70059-fig-0008" class="usa-link">8</a>). At 48 h, HaCaT cells exhibited a significant increase (<em>p</em> &lt; 0.001) in the number of zingerone and combination treated cells in the sub‐G<sub>1</sub> phase, followed by a decrease in the number of cells in the G<sub>1</sub> phase (<em>p</em> &lt; 0.0001; Figure <a href="#cep70059-fig-0008" class="usa-link">8</a>). NOC‐treated cells exhibited a significant increase (<em>p</em> &lt; 0.001) in the number of cells in the G<sub>2</sub>/M phase in the B16‐F10 cells at 48 h and HaCaT cells at 48 and 72 h, indicative of a G<sub>2</sub>/M cell cycle block.</p>
<figure class="fig xbox font-sm" id="cep70059-fig-0008"><h5 class="obj_head">FIGURE 8.</h5>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7b3/12283137/ecc38f00250b/CEP-52-0-g003.jpg" loading="lazy" id="jats-graphic-15" height="454" width="709" alt="FIGURE 8"></p>
<div class="p text-right font-secondary"><a href="figure/cep70059-fig-0008/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The effect of the half maximal inhibitory concentrations of MAZ‐51 and zingerone on the B16‐F10 and HaCaT cells on cell cycle progression at 48 and 72 h. *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ****<em>p</em> &lt; 0.0001 indicates significance in comparison to the control. Graphs were designed using GraphPad Prism version 9.5.1.</p></figcaption></figure><p>MAZ‐51, zingerone, and combination treatment at IC<sub>50</sub> had no significant effect on the B16‐F10 cells at 72 h. HaCaT cells treated with zingerone and combination treatment at IC<sub>50</sub> resulted in a significant increase (<em>p</em> &lt; 0.01) in cell numbers in the sub‐G<sub>1</sub> phase at 72 h. This was followed by a significant decrease (<em>p</em> &lt; 0.001) in cell numbers in the G<sub>1</sub> phase (Figure <a href="#cep70059-fig-0008" class="usa-link">8</a>). MAZ‐51‐treated HaCaT cells resulted in a significant decrease (<em>p</em> &lt; 0.01) in cell numbers in the G<sub>1</sub> phase at 72 h (Figure <a href="#cep70059-fig-0008" class="usa-link">8</a>).</p></section></section><section id="cep70059-sec-0025"><h3 class="pmc_sec_title">3.5. The Effects of Vascular Endothelial Growth Factor on the B16‐F10 and HaCaT Cells</h3>
<p>B16‐F10 cells treated with MAZ‐51 and VEGF at 20 and 60 ng/mL (MAZ‐51/VEGF+) resulted in an increase in the percentage number of cells at 48 and 72 h in comparison to cells that were only treated with MAZ‐51 (MAZ‐51/VEGF−) (<em>p</em> &lt; 0.05; Tables <a href="#cep70059-tbl-0003" class="usa-link">3</a> and <a href="#cep70059-tbl-0004" class="usa-link">4</a>). However, MAZ‐51/VEGF+ resulted in a decrease in cell numbers in the HaCaT cells at 48 and 72 h (Tables <a href="#cep70059-tbl-0003" class="usa-link">3</a> and <a href="#cep70059-tbl-0004" class="usa-link">4</a>). Zingerone/VEGF+ and combination treatment/VEGF+ treated B16‐F10 cells resulted in a decrease in percentage cell numbers compared to the VEGF− cells at 48 and 72 h (<em>p</em> &lt; 0.0001; Tables <a href="#cep70059-tbl-0003" class="usa-link">3</a> and <a href="#cep70059-tbl-0004" class="usa-link">4</a>). HaCaT cells exhibited a decrease in percentage cell numbers in zingerone/VEGF+ and combination/VEGF+ cells at 48 h (<em>p</em> &lt; 0.0001; Tables <a href="#cep70059-tbl-0003" class="usa-link">3</a> and <a href="#cep70059-tbl-0004" class="usa-link">4</a>) however, an increase in cell numbers was observed at 72 h in comparison to the VEGF− cells (<em>p</em> &lt; 0.001; Tables <a href="#cep70059-tbl-0003" class="usa-link">3</a> and <a href="#cep70059-tbl-0004" class="usa-link">4</a>).</p>
<section class="tw xbox font-sm" id="cep70059-tbl-0003"><h4 class="obj_head">TABLE 3.</h4>
<div class="caption p"><p>Table depicting the effect of vascular endothelial growth factor at 20 ng/mL on percentage cell numbers in the B16‐F10 and HaCaT cells at 48 and 72 h.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" colspan="2" valign="bottom"></th>
<th align="center" colspan="6" valign="bottom" rowspan="1">Treatment compounds</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" colspan="2" valign="bottom" rowspan="1">MAZ‐51</th>
<th align="center" colspan="2" valign="bottom" rowspan="1">Zingerone</th>
<th align="center" colspan="2" valign="bottom" rowspan="1">MAZ‐51 + Zingerone</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Timelines</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Cell lines</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF−</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF+</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF−</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF+</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF−</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF+</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">48 h</td>
<td align="center" valign="top" rowspan="1" colspan="1">B16‐F10</td>
<td align="center" valign="top" rowspan="1" colspan="1">45%*** (9.176–81.60)</td>
<td align="center" valign="top" rowspan="1" colspan="1">69%* (21.62–116.1)</td>
<td align="center" valign="top" rowspan="1" colspan="1">34%**** (27.91–39.80)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19%**** (17.30–19.71)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30%**** (14.20–45.12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18%**** (4.456–31.19)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">HaCats</td>
<td align="center" valign="top" rowspan="1" colspan="1">77%* (58.99–94.70)</td>
<td align="center" valign="top" rowspan="1" colspan="1">70%** (42.59–98.17)</td>
<td align="center" valign="top" rowspan="1" colspan="1">51%*** (17.03–84.24)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30%**** (9.906–50.48)</td>
<td align="center" valign="top" rowspan="1" colspan="1">39%**** (29.93–47.34)</td>
<td align="center" valign="top" rowspan="1" colspan="1">31%**** (7.266–54.15)</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">72 h</td>
<td align="center" valign="top" rowspan="1" colspan="1">B16‐F10</td>
<td align="center" valign="top" rowspan="1" colspan="1">48%**** (23.47–73.99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">64%** (33.56–93.45)</td>
<td align="center" valign="top" rowspan="1" colspan="1">49%**** (21.56–76.41)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35%**** (26.51–44.03)</td>
<td align="center" valign="top" rowspan="1" colspan="1">41%**** (34.57–46.60)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35%**** (21.60–49.30)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">HaCaTs</td>
<td align="center" valign="top" rowspan="1" colspan="1">85%* (67.93–102.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">76% (43.81–107.5)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28%**** (12.66–42.63)</td>
<td align="center" valign="top" rowspan="1" colspan="1">43%*** (9.769–75.93)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28%**** (18.53–37.64)</td>
<td align="center" valign="top" rowspan="1" colspan="1">35%**** (15.27–54.66)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cep70059-tbl-0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="cep70059-note-0003"><p>
<em>Note:</em> The confidence intervals are indicated in the brackets. *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ****<em>p</em> &lt; 0.0001 indicate significance in comparison to the control.</p></div></div></section><section class="tw xbox font-sm" id="cep70059-tbl-0004"><h4 class="obj_head">TABLE 4.</h4>
<div class="caption p"><p>Table depicting the effect of vascular endothelial growth factor at 60 ng/mL on percentage cell numbers in the B16‐F10 and HaCaT cells at 48 and 72 h.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<col align="left" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<col align="center" span="1">
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" rowspan="2" colspan="2" valign="bottom"></th>
<th align="center" colspan="6" valign="bottom" rowspan="1">Treatment compounds</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="center" colspan="2" valign="bottom" rowspan="1">MAZ‐51</th>
<th align="center" colspan="2" valign="bottom" rowspan="1">Zingerone</th>
<th align="center" colspan="2" valign="bottom" rowspan="1">MAZ‐51 + Zingerone</th>
</tr>
<tr style="border-bottom:solid 1px #000000">
<th align="left" valign="bottom" rowspan="1" colspan="1">Timelines</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">Cell lines</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF−</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF+</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF−</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF+</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF−</th>
<th align="center" valign="bottom" rowspan="1" colspan="1">VEGF+</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">48 h</td>
<td align="center" valign="top" rowspan="1" colspan="1">B16‐F10</td>
<td align="center" valign="top" rowspan="1" colspan="1">45%*** (9.176–81.60)</td>
<td align="center" valign="top" rowspan="1" colspan="1">66%*** (46.25–85.07)</td>
<td align="center" valign="top" rowspan="1" colspan="1">34%**** (27.91–39.80)</td>
<td align="center" valign="top" rowspan="1" colspan="1">19%**** (15.40–22.98)</td>
<td align="center" valign="top" rowspan="1" colspan="1">30%**** (14.20–45.12)</td>
<td align="center" valign="top" rowspan="1" colspan="1">18%**** (2.740–33.62)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">HaCaTs</td>
<td align="center" valign="top" rowspan="1" colspan="1">77%* (58.99–94.70)</td>
<td align="center" valign="top" rowspan="1" colspan="1">68%* (41.68–93.70)</td>
<td align="center" valign="top" rowspan="1" colspan="1">51%*** (17.03–84.24)</td>
<td align="center" valign="top" rowspan="1" colspan="1">38%**** (11.44–64.29)</td>
<td align="center" valign="top" rowspan="1" colspan="1">39%**** (29.93–47.34)</td>
<td align="center" valign="top" rowspan="1" colspan="1">43%**** (17.44–69.06)</td>
</tr>
<tr>
<td align="left" rowspan="2" valign="top" colspan="1">72 h</td>
<td align="center" valign="top" rowspan="1" colspan="1">B16‐F10</td>
<td align="center" valign="top" rowspan="1" colspan="1">48%**** (23.47–73.99)</td>
<td align="center" valign="top" rowspan="1" colspan="1">65%** (37.94–91.29)</td>
<td align="center" valign="top" rowspan="1" colspan="1">49%**** (21.56–76.41)</td>
<td align="center" valign="top" rowspan="1" colspan="1">39%**** (31.70–45.80)</td>
<td align="center" valign="top" rowspan="1" colspan="1">41%**** (34.57–46.60)</td>
<td align="center" valign="top" rowspan="1" colspan="1">39%**** (25.79–52.83)</td>
</tr>
<tr>
<td align="center" valign="top" rowspan="1" colspan="1">HaCaTs</td>
<td align="center" valign="top" rowspan="1" colspan="1">85%* (67.93–102.4)</td>
<td align="center" valign="top" rowspan="1" colspan="1">80% (61.05–97.96)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28%**** (12.66–42.63)</td>
<td align="center" valign="top" rowspan="1" colspan="1">45%**** (15.11–74.35)</td>
<td align="center" valign="top" rowspan="1" colspan="1">28%**** (18.53–37.64)</td>
<td align="center" valign="top" rowspan="1" colspan="1">37%**** (14.07–59.84)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/cep70059-tbl-0004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="cep70059-note-0004"><p>
<em>Note:</em> The confidence intervals are indicated in the brackets. *<em>p</em> &lt; 0.05, **<em>p</em> &lt; 0.01, ***<em>p</em> &lt; 0.001, ****<em>p</em> &lt; 0.0001 indicates significance in comparison to the control.</p></div></div></section></section></section><section id="cep70059-sec-0026"><h2 class="pmc_sec_title">4. Discussion</h2>
<p>The global incidence of cancer continues to rise; as such, there is a need to develop novel treatment strategies. Phytochemicals have acquired substantial attention as adjuvant therapy to inhibit cancer growth without eliciting cytotoxic effects on noncancerous cells [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>]. Therefore, this study investigated the individual and combined effects of MAZ‐51 and zingerone on melanoma cell proliferation. The study findings indicate that MAZ‐51 and zingerone are cytotoxic to the B16‐F10 melanoma cells. In addition, the compounds induced morphological changes indicating cell death and resulted in a cell‐cycle arrest.</p>
<p>Consistent with results obtained by Scholtz and Mabeta who recorded a significant decrease in the cell viability of endothelial and B16‐F10 melanoma cells treated with MAZ‐51 [<a href="#cep70059-bib-0023" class="usa-link" aria-describedby="cep70059-bib-0023">23</a>], this study observed a significant decrease in cell numbers in B16‐F10 cells at 72 h at concentrations of 0.004 and 0.005 mg/mL. MAZ‐51 had no significant effect on the HaCaT cells at 24, 48 and 72 h, thus demonstrating differential toxicity in the cell lines. This is further confirmed by the experimental IC<sub>50</sub> data, where MAZ‐51 reduced cell numbers to 45% (<em>p</em> &lt; 0.001) and 49% (<em>p</em> &lt; 0.0001) at 48 and 72 h, respectively in the B16‐F10 cells. In the HaCaT cells, MAZ‐51 reduced cell numbers to 77% (<em>p</em> &lt; 0.05) and 85% (<em>p</em> &lt; 0.05) at 48 and 72 h, respectively. This data indicates that MAZ‐51 is cytotoxic; however, it is more potent in the B16‐F10 cells compared to the HaCaT cells, suggesting its specificity to transformed cancerous cells.</p>
<p>Current literature supports the use of phytochemicals as potential cancer treatments, suggesting that they will result in therapeutic effects, with limited cytotoxicity to noncancerous cells compared to current synthetic drugs [<a href="#cep70059-bib-0026" class="usa-link" aria-describedby="cep70059-bib-0026">26</a>, <a href="#cep70059-bib-0027" class="usa-link" aria-describedby="cep70059-bib-0027">27</a>]. However, this study observed that zingerone was more cytotoxic to the B16‐F10 and HaCaT cells compared to treatment with MAZ‐51. The literature also states that phytochemicals are required at higher concentrations to elicit therapeutic effects in cancer cells [<a href="#cep70059-bib-0017" class="usa-link" aria-describedby="cep70059-bib-0017">17</a>, <a href="#cep70059-bib-0018" class="usa-link" aria-describedby="cep70059-bib-0018">18</a>]. Findings from this study indicate that the increased concentrations of zingerone decreased the B16‐F10 cell numbers. An enhanced cytotoxic effect was observed in the noncancerous HaCaT cell lines at IC<sub>50</sub> at 48 and 72 h, with enhanced toxicity observed at 72 h. To combat this, zingerone's IC<sub>25</sub> was determined and increased the HaCaT cell numbers, indicating a potential therapeutic concentration. In addition, zingerone at 48 h was more cytotoxic to the B16‐F10 compared to at 72 h. This demonstrates that treatment at 48 h yielded optimal cytotoxic effects in the B16‐F10 cells with reduced toxicity exerted on the HaCaT cells. To elucidate the additional characteristics of the compounds of interest, morphological studies were done on the B16‐F10 and HaCaT cells treated with MAZ‐51, zingerone, and a combination of MAZ‐51 and zingerone at IC<sub>50</sub> at 48 and 72 h.</p>
<p>Morphological observations using PlasDIC and H&amp;E staining showed the formation of cellular protrusions and apoptotic bodies in zingerone‐treated cells. This observation is in agreement with findings by Chu et al., who observed cytoskeleton elongations and dendrite‐like structures in zingerone‐treated B16‐F10 cells [<a href="#cep70059-bib-0028" class="usa-link" aria-describedby="cep70059-bib-0028">28</a>]. Consistent with results recorded by Park et al. in glioma cells [<a href="#cep70059-bib-0029" class="usa-link" aria-describedby="cep70059-bib-0029">29</a>], MAZ‐51‐treated B16‐F10 and HaCaT cells exhibited cell rounding, karyorrhexis, pyknosis, and cell swelling, which are characteristic of apoptosis and necrosis. The morphology data indicate that MAZ‐51 and zingerone are cytotoxic and induce structural changes that indicate cell death. Since the study observed structural changes that are characteristic of both apoptosis and necrosis, the type of cell death induced by the compounds needs to be further investigated. To further examine the effects of MAZ‐51 and zingerone on melanoma growth and proliferation, flow cytometry analysis was used to determine the effects of the compounds on cell cycle progression.</p>
<p>Flow cytometry analysis exhibited a significant increase in the number of cells in the sub‐G<sub>1</sub> phase of B16‐F10 cells treated with MAZ‐51 at 48 h, and a non‐significant effect was observed at 72 h. MAZ‐51 at 72 h displayed non‐significant effects on cell cycle progression in the B16‐F10 cells. HaCaT cells treated with MAZ‐51 at 48 and 72 h exhibited a non‐significant increase in cells in the sub‐G<sub>1</sub> phase, followed by a significant decrease in cell numbers in the G<sub>1</sub> phase at 72 h. This indicates that MAZ‐51 inhibits HaCaT cell proliferation without inducing cell death. These findings are supported by results obtained by Park et al., who observed the effects of MAZ‐51 on the rat C6 and human U251MG glioma cells, where the cytotoxic effects of MAZ‐51 were non‐significant on the control cell lines [<a href="#cep70059-bib-0029" class="usa-link" aria-describedby="cep70059-bib-0029">29</a>]. This indicates that MAZ‐51 possesses antiproliferative properties; however, its cytotoxic properties target transformed cells. In addition, as MAZ‐51 induced significant changes at 48 h in the B16‐F10, with limited toxicity observed in the HaCaTs at 48 h, this indicates that treatment at this timeline yields maximal results, which is confirmed by the cell viability data.</p>
<p>Zingerone‐treated B16‐F10 cells resulted in a significant increase in the percentage of cells in the sub‐G<sub>1</sub> phase at 48 h, with a less potent increase observed at 72 h. Similar results were observed in zingerone‐treated HaCaT cells. Choi et al. observed an increase in the number of cells in prometaphase and a decrease in cells in metaphase in zingerone‐treated neuroblastoma cells, indicating a mitotic arrest [<a href="#cep70059-bib-0015" class="usa-link" aria-describedby="cep70059-bib-0015">15</a>]. This data indicates that zingerone is cytotoxic to the B16‐F10 and HaCaT cells. The quantitative flow cytometry data is supported by the qualitative data, suggesting that zingerone is toxic to the cells and induces apoptosis.</p>
<p>Angiogenic and lymphangiogenic factors such as VEGFs and their corresponding receptors are dysregulated during carcinogenesis and thus are critical targets for cancer therapy [<a href="#cep70059-bib-0029" class="usa-link" aria-describedby="cep70059-bib-0029">29</a>]. MAZ‐51 inhibits VEGF‐C‐induced phosphorylation of VEGFR‐3, inhibiting proliferation [<a href="#cep70059-bib-0030" class="usa-link" aria-describedby="cep70059-bib-0030">30</a>]. This study observed an increase in cell numbers in MAZ‐51/VEGF+ cells compared to MAZ‐51/VEGF− in the B16‐F10 cells. Even though this study utilised non‐specific VEGF, the findings provide a potential mechanism of action utilised by the treating compounds to inhibit cell proliferation and survival. Given that MAZ‐51 specifically targets VEGFR‐3, the results suggest that the additional VEGF activates alternative signalling pathways such as VEGFR‐2 [<a href="#cep70059-bib-0030" class="usa-link" aria-describedby="cep70059-bib-0030">30</a>] that are activated in melanoma progression, thus explaining the increase in cell numbers observed in MAZ‐51/VEGF+ cells compared to MAZ‐51/VEGF− cells. Conversely, zingerone‐treated B16‐F10 cells supplemented with VEGF resulted in a decrease in cell numbers compared to VEGF− cells. This is supported by the results by Kung et al., who recorded a decrease in VEGF and VEGFR expression in endothelial cells treated with zingerone nanoparticles [<a href="#cep70059-bib-0031" class="usa-link" aria-describedby="cep70059-bib-0031">31</a>]. This data suggests that zingerone is cytotoxic in the presence of VEGF, indicating that it diminishes proliferation and survival by targeting VEGFs.</p>
<p>Literature recommends the use of phytochemicals as an alternative treatment for cancer due to their potential therapeutic value. Literature has highlighted that the individual use of phytochemicals often exhibits limited bioavailability and requires high concentrations to induce cytotoxic effects. When combined with pharmacological agents, phytochemicals demonstrate enhanced anti‐inflammatory and antioxidant properties [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>]. This study investigated the combined effects of MAZ‐51 and zingerone on melanoma cell proliferation. The findings revealed that combination treatment significantly decreased cell numbers, induced morphological changes such as cellular protrusions and cell rounding, and caused a mitotic block in the B16‐F10 melanoma cells.</p>
<p>However, this study recorded a combination index (CI) that is greater than one, indicating antagonism, at both inhibitory concentrations (IC<sub>50</sub> and IC<sub>25</sub>) and timelines. The consistently elevated CI indicates that the antagonistic effects of MAZ‐51 and zingerone are independent of the compound concentrations but are possibly reliant on the mechanistic interactions of the compounds and thus, further indicates the incompatibility of MAZ‐51 and zingerone. This antagonistic effect may be attributed to phytochemical‐drug interactions that alter drug metabolising enzymes or transport proteins, modification of the chemotherapeutic by the phytochemical and incompatibility of the two drugs, resulting in the modification of the physical properties of the drugs such as drug solubility and stability [<a href="#cep70059-bib-0003" class="usa-link" aria-describedby="cep70059-bib-0003">3</a>, <a href="#cep70059-bib-0032" class="usa-link" aria-describedby="cep70059-bib-0032">32</a>]. Previous studies have reported additive or synergistic effects of phytochemicals with pharmacological agents, supporting their role as adjuvant therapies. However, the antagonistic effects observed in this study highlight the significance of performing phytochemical‐drug compatibility studies by carefully evaluating drug interactions, delivery mechanisms and compound compatibility [<a href="#cep70059-bib-0013" class="usa-link" aria-describedby="cep70059-bib-0013">13</a>, <a href="#cep70059-bib-0033" class="usa-link" aria-describedby="cep70059-bib-0033">33</a>]. Given the above results, we recommend that future studies investigating the anticancer effects of MAZ‐51 and zingerone should consider an individual compound approach to optimise therapeutic outcomes. In addition, as both zingerone and MAZ‐51 individually possess chemotherapeutic properties, other combination therapies with phytochemicals and the use of nanoparticles may be explored to further enhance their chemotherapeutic effects. Zingerone has effectively inhibited the growth and proliferation of cancers such as neuroblastoma, prostate cancer and breast cancer, thus indicating its potential as a cancer therapeutic [<a href="#cep70059-bib-0015" class="usa-link" aria-describedby="cep70059-bib-0015">15</a>, <a href="#cep70059-bib-0016" class="usa-link" aria-describedby="cep70059-bib-0016">16</a>, <a href="#cep70059-bib-0034" class="usa-link" aria-describedby="cep70059-bib-0034">34</a>].</p></section><section id="cep70059-sec-0027"><h2 class="pmc_sec_title">5. Conclusion</h2>
<p>In conclusion, the findings of this study demonstrate that MAZ‐51 and zingerone effectively inhibit melanoma cell proliferation and survival, with zingerone showing promise as a potential therapeutic agent for melanoma treatment. While cytotoxic effects were observed at zingerone IC<sub>50</sub> in both B16‐F10 and HaCaT cells, treatment at IC<sub>25</sub> significantly inhibited B16‐F10 cell proliferation while exhibiting reduced toxicity in HaCaT cells. The results underscore the potential of zingerone as an alternative treatment option. However, due to the observed antagonistic interaction between MAZ‐51 and zingerone both at IC<sub>50</sub> and IC<sub>25</sub> (resulting in a CI that is greater than one), we recommend that future studies investigate the individual effects of MAZ‐51 at IC<sub>50</sub> and zingerone at IC<sub>25</sub>. Given that melanoma relies on the interplay of various signalling pathways to promote proliferation and survival, we recommend that future studies investigate the effects of zingerone on prominent signalling pathways such as CXCR4/CXCL12, VEGFR‐3/VEGF‐C, and TGF‐β/TGFβRI to further elucidate the mechanistic action undertaken by the compounds to inhibit melanoma progression.</p></section><section id="cep70059-sec-0028"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>
<strong>Kganya Letsoalo:</strong> experimental and data analysis (lead); conceptualisation (equal), writing – original draft (lead), writing – review and editing (equal). <strong>Charlise Basson:</strong> writing – review and editing (equal). <strong>Trevor Nyakudya:</strong> conceptualisation (equal), writing – review and editing (equal). <strong>Yvette Hlophe:</strong> conceptualisation (equal), writing – review and editing (equal).</p></section><section id="cep70059-sec-0029"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflicts of interest.</p></section><section id="cep70059-sec-0032"><h2 class="pmc_sec_title">Peer Review</h2>
<p>The peer review history for this article is available at <a href="https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/1440-1681.70059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.webofscience.com/api/gateway/wos/peer‐review/10.1111/1440‐1681.70059</a>.</p></section><section id="notes1"><p>

Letsoalo K., Basson C., Nyakudya T., and Hlophe Y., “Exploring Phytochemical Adjuvant Therapy in Melanoma Treatment: The Effects of MAZ‐51 and Zingerone on Melanoma Cell Proliferation,” Clinical and Experimental Pharmacology and Physiology
52, no. 9 (2025): e70059, 10.1111/1440-1681.70059.
</p>
<section id="cep70059-ntgp-0001" class="fn-group"><div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="cep70059-note-0001"><p>
<strong>Funding:</strong> This work was supported by the National Research Foundation (NRF) of South Africa (N1F580 A1F685) and the University of Pretoria's postgraduate funding scheme.</p></div></div></section></section><section id="cep70059-sec-0031"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section><section id="cep70059-bibl-0001" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="cep70059-bibl-0001_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="cep70059-bib-0001">
<span class="label">1.</span><cite>
Fantini M., Benvenuto M., Masuelli L., et al., “In Vitro and In Vivo Antitumoral Effects of Combinations of Polyphenols, or Polyphenols and Anticancer Drugs: Perspectives on Cancer Treatment,” International Journal of Molecular Sciences
16, no. 5 (2015): 9236–9282, 10.3390/ijms16059236.
</cite> [<a href="https://doi.org/10.3390/ijms16059236" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4463587/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25918934/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=In%20Vitro%20and%20In%C2%A0Vivo%20Antitumoral%20Effects%20of%20Combinations%20of%20Polyphenols,%20or%20Polyphenols%20and%20Anticancer%20Drugs:%20Perspectives%20on%20Cancer%20Treatment&amp;author=M.%20Fantini&amp;author=M.%20Benvenuto&amp;author=L.%20Masuelli&amp;volume=16&amp;issue=5&amp;publication_year=2015&amp;pages=9236-9282&amp;pmid=25918934&amp;doi=10.3390/ijms16059236&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0002">
<span class="label">2.</span><cite>
Sagbo I. J. and Otang‐Mbeng W., “Plants Used for the Traditional Management of Cancer in the Eastern Cape Province of South Africa: A Review of Ethnobotanical Surveys, Ethnopharmacological Studies and Active Phytochemicals,” Molecules
26, no. 15 (2021): 4639, 10.3390/molecules26154639.
</cite> [<a href="https://doi.org/10.3390/molecules26154639" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8347031/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34361790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Molecules&amp;title=Plants%20Used%20for%20the%20Traditional%20Management%20of%20Cancer%20in%20the%20Eastern%20Cape%20Province%20of%20South%20Africa:%20A%20Review%20of%20Ethnobotanical%20Surveys,%20Ethnopharmacological%20Studies%20and%20Active%20Phytochemicals&amp;author=I.%20J.%20Sagbo&amp;author=W.%20Otang%E2%80%90Mbeng&amp;volume=26&amp;issue=15&amp;publication_year=2021&amp;pages=4639&amp;pmid=34361790&amp;doi=10.3390/molecules26154639&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0003">
<span class="label">3.</span><cite>
Letsoalo K., Nortje E., Patrick S., Nyakudya T., and Hlophe Y., “Decoding the Synergistic Potential of MAZ‐51 and Zingerone as Therapy for Melanoma Treatment in Alignment With Sustainable Development Goals,” Cell Biochemistry and Function
42, no. 2 (2024): e3950, 10.1002/cbf.3950.
</cite> [<a href="https://doi.org/10.1002/cbf.3950" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38348768/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Biochemistry%20and%20Function&amp;title=Decoding%20the%20Synergistic%20Potential%20of%20MAZ%E2%80%9051%20and%20Zingerone%20as%20Therapy%20for%20Melanoma%20Treatment%20in%20Alignment%20With%20Sustainable%20Development%20Goals&amp;author=K.%20Letsoalo&amp;author=E.%20Nortje&amp;author=S.%20Patrick&amp;author=T.%20Nyakudya&amp;author=Y.%20Hlophe&amp;volume=42&amp;issue=2&amp;publication_year=2024&amp;pages=e3950&amp;pmid=38348768&amp;doi=10.1002/cbf.3950&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0004">
<span class="label">4.</span><cite>
Sever R. and Brugge J. S., “Signal Transduction in Cancer,” Cold Spring Harbor Perspectives in Medicine
5, no. 4 (2015): a006098, 10.1101/cshperspect.a006098.
</cite> [<a href="https://doi.org/10.1101/cshperspect.a006098" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4382731/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25833940/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cold%20Spring%20Harbor%20Perspectives%20in%20Medicine&amp;title=Signal%20Transduction%20in%20Cancer&amp;author=R.%20Sever&amp;author=J.%20S.%20Brugge&amp;volume=5&amp;issue=4&amp;publication_year=2015&amp;pages=a006098&amp;pmid=25833940&amp;doi=10.1101/cshperspect.a006098&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0005">
<span class="label">5.</span><cite>
Ju W., Cai H. H., Zheng W., et al., “Cross‐Talk Between Lymphangiogenesis and Malignant Melanoma Cells: New Opinions on Tumour Drainage and Immunization (Review),” Oncology Letters
27, no. 2 (2024): 81, 10.3892/ol.2024.14215.
</cite> [<a href="https://doi.org/10.3892/ol.2024.14215" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10797314/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38249813/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncology%20Letters&amp;title=Cross%E2%80%90Talk%20Between%20Lymphangiogenesis%20and%20Malignant%20Melanoma%20Cells:%20New%20Opinions%20on%20Tumour%20Drainage%20and%20Immunization%20(Review)&amp;author=W.%20Ju&amp;author=H.%20H.%20Cai&amp;author=W.%20Zheng&amp;volume=27&amp;issue=2&amp;publication_year=2024&amp;pages=81&amp;pmid=38249813&amp;doi=10.3892/ol.2024.14215&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0006">
<span class="label">6.</span><cite>
Kirkin V., Mazitschek R., Krishnan J., et al., “Characterization of Indolinones Which Preferentially Inhibit VEGF‐C‐ and VEGF‐D‐Induced Activation of VEGFR‐3 Rather Than VEGFR‐2,” European Journal of Biochemistry
268, no. 21 (2001): 5530–5540, 10.1046/j.1432-1033.2001.02476.x.
</cite> [<a href="https://doi.org/10.1046/j.1432-1033.2001.02476.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11683876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=European%20Journal%20of%20Biochemistry&amp;title=Characterization%20of%20Indolinones%20Which%20Preferentially%20Inhibit%20VEGF%E2%80%90C%E2%80%90%20and%20VEGF%E2%80%90D%E2%80%90Induced%20Activation%20of%20VEGFR%E2%80%903%20Rather%20Than%20VEGFR%E2%80%902&amp;author=V.%20Kirkin&amp;author=R.%20Mazitschek&amp;author=J.%20Krishnan&amp;volume=268&amp;issue=21&amp;publication_year=2001&amp;pages=5530-5540&amp;pmid=11683876&amp;doi=10.1046/j.1432-1033.2001.02476.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0007">
<span class="label">7.</span><cite>
Kirkin V., Thiele W., Baumann P., et al., “MAZ51, an Indolinone That Inhibits Endothelial Cell and Tumor Cell Growth in Vitro, Suppresses Tumor Growth in Vivo,” International Journal of Cancer
112, no. 6 (2004): 986–993, 10.1002/ijc.20509.
</cite> [<a href="https://doi.org/10.1002/ijc.20509" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15386354/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Cancer&amp;title=MAZ51,%20an%20Indolinone%20That%20Inhibits%20Endothelial%20Cell%20and%20Tumor%20Cell%20Growth%20in%20Vitro,%20Suppresses%20Tumor%20Growth%20in%20Vivo&amp;author=V.%20Kirkin&amp;author=W.%20Thiele&amp;author=P.%20Baumann&amp;volume=112&amp;issue=6&amp;publication_year=2004&amp;pages=986-993&amp;pmid=15386354&amp;doi=10.1002/ijc.20509&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0008">
<span class="label">8.</span><cite>
Garcia‐Oliveira P., Otero P., Pereira A. G., et al., “Status and Challenges of Plant‐Anticancer Compounds in Cancer Treatment,” Pharmaceuticals (Basel)
14, no. 2 (2021): 157, 10.3390/ph14020157.
</cite> [<a href="https://doi.org/10.3390/ph14020157" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7918405/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33673021/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Pharmaceuticals%20(Basel)&amp;title=Status%20and%20Challenges%20of%20Plant%E2%80%90Anticancer%20Compounds%20in%20Cancer%20Treatment&amp;author=P.%20Garcia%E2%80%90Oliveira&amp;author=P.%20Otero&amp;author=A.%20G.%20Pereira&amp;volume=14&amp;issue=2&amp;publication_year=2021&amp;pages=157&amp;pmid=33673021&amp;doi=10.3390/ph14020157&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0009">
<span class="label">9.</span><cite>
Sak K., “Chemotherapy and Dietary Phytochemical Agents,” Chemotherapy Research and Practice
2012 (2012): 282570, 10.1155/2012/282570.</cite> [<a href="https://doi.org/10.1155/2012/282570" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3539428/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23320169/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chemotherapy%20Research%20and%20Practice&amp;title=Chemotherapy%20and%20Dietary%20Phytochemical%20Agents&amp;author=K.%20Sak&amp;volume=2012&amp;publication_year=2012&amp;pages=282570&amp;pmid=23320169&amp;doi=10.1155/2012/282570&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0010">
<span class="label">10.</span><cite>
Alqosaibi A. I., “Nanocarriers for Anticancer Drugs: Challenges and Perspectives,” Saudi Journal of Biological Sciences
29, no. 6 (2022): 103298, 10.1016/j.sjbs.2022.103298.
</cite> [<a href="https://doi.org/10.1016/j.sjbs.2022.103298" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9130109/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35645591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Saudi%20Journal%20of%20Biological%20Sciences&amp;title=Nanocarriers%20for%20Anticancer%20Drugs:%20Challenges%20and%20Perspectives&amp;author=A.%20I.%20Alqosaibi&amp;volume=29&amp;issue=6&amp;publication_year=2022&amp;pages=103298&amp;pmid=35645591&amp;doi=10.1016/j.sjbs.2022.103298&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0011">
<span class="label">11.</span><cite>
Choudhari A. S., Mandave P. C., Deshpande M., Ranjekar P., and Prakash O., “Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice,” Frontiers in Pharmacology
10 (2019): 1614, 10.3389/fphar.2019.01614.
</cite> [<a href="https://doi.org/10.3389/fphar.2019.01614" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7025531/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32116665/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Pharmacology&amp;title=Phytochemicals%20in%20Cancer%20Treatment:%20From%20Preclinical%20Studies%20to%20Clinical%20Practice&amp;author=A.%20S.%20Choudhari&amp;author=P.%20C.%20Mandave&amp;author=M.%20Deshpande&amp;author=P.%20Ranjekar&amp;author=O.%20Prakash&amp;volume=10&amp;publication_year=2019&amp;pages=1614&amp;pmid=32116665&amp;doi=10.3389/fphar.2019.01614&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0012">
<span class="label">12.</span><cite>
Sofowora A., Ogunbodede E., and Onayade A., “The Role and Place of Medicinal Plants in the Strategies for Disease Prevention,” African Journal of Traditional, Complementary, and Alternative Medicines
10, no. 5 (2013): 210–229, 10.4314/ajtcam.v10i5.2.</cite> [<a href="https://doi.org/10.4314/ajtcam.v10i5.2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3847409/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24311829/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=African%20Journal%20of%20Traditional,%20Complementary,%20and%20Alternative%20Medicines&amp;title=The%20Role%20and%20Place%20of%20Medicinal%20Plants%20in%20the%20Strategies%20for%20Disease%20Prevention&amp;author=A.%20Sofowora&amp;author=E.%20Ogunbodede&amp;author=A.%20Onayade&amp;volume=10&amp;issue=5&amp;publication_year=2013&amp;pages=210-229&amp;pmid=24311829&amp;doi=10.4314/ajtcam.v10i5.2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0013">
<span class="label">13.</span><cite>
Ayaz M., Nawaz A., Ahmad S., et al., “Underlying Anticancer Mechanisms and Synergistic Combinations of Phytochemicals With Cancer Chemotherapeutics: Potential Benefits and Risks,” Journal of Food Quality
2022, no. 1 (2022): 1189034.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Food%20Quality&amp;title=Underlying%20Anticancer%20Mechanisms%20and%20Synergistic%20Combinations%20of%20Phytochemicals%20With%20Cancer%20Chemotherapeutics:%20Potential%20Benefits%20and%20Risks&amp;author=M.%20Ayaz&amp;author=A.%20Nawaz&amp;author=S.%20Ahmad&amp;volume=2022&amp;issue=1&amp;publication_year=2022&amp;pages=1189034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0014">
<span class="label">14.</span><cite>
Nikkhah Bodagh M., Maleki I., and Hekmatdoost A., “Ginger in Gastrointestinal Disorders: A Systematic Review of Clinical Trials,” Food Science &amp; Nutrition
7, no. 1 (2019): 96–108, 10.1002/fsn3.807.
</cite> [<a href="https://doi.org/10.1002/fsn3.807" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6341159/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30680163/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Food%20Science%20&amp;%20Nutrition&amp;title=Ginger%20in%20Gastrointestinal%20Disorders:%20A%20Systematic%20Review%20of%20Clinical%20Trials&amp;author=M.%20Nikkhah%20Bodagh&amp;author=I.%20Maleki&amp;author=A.%20Hekmatdoost&amp;volume=7&amp;issue=1&amp;publication_year=2019&amp;pages=96-108&amp;pmid=30680163&amp;doi=10.1002/fsn3.807&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0015">
<span class="label">15.</span><cite>
Choi J. S., Ryu J., Bae W. Y., et al., “Zingerone Suppresses Tumor Development Through Decreasing Cyclin D1 Expression and Inducing Mitotic Arrest,” International Journal of Molecular Sciences
19, no. 9 (2018): 2832, 10.3390/ijms19092832.
</cite> [<a href="https://doi.org/10.3390/ijms19092832" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6163242/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30235818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=International%20Journal%20of%20Molecular%20Sciences&amp;title=Zingerone%20Suppresses%20Tumor%20Development%20Through%20Decreasing%20Cyclin%20D1%20Expression%20and%20Inducing%20Mitotic%20Arrest&amp;author=J.%20S.%20Choi&amp;author=J.%20Ryu&amp;author=W.%20Y.%20Bae&amp;volume=19&amp;issue=9&amp;publication_year=2018&amp;pages=2832&amp;pmid=30235818&amp;doi=10.3390/ijms19092832&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0016">
<span class="label">16.</span><cite>
Qian S., Fang H., Zheng L., and Liu M., “Zingerone Suppresses Cell Proliferation via Inducing Cellular Apoptosis and Inhibition of the PI3K/AKT/mTOR Signaling Pathway in Human Prostate Cancer PC‐3 Cells,” Journal of Biochemical and Molecular Toxicology
35, no. 1 (2021): e22611, 10.1002/jbt.22611.
</cite> [<a href="https://doi.org/10.1002/jbt.22611" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32905641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biochemical%20and%20Molecular%20Toxicology&amp;title=Zingerone%20Suppresses%20Cell%20Proliferation%20via%20Inducing%20Cellular%20Apoptosis%20and%20Inhibition%20of%20the%20PI3K/AKT/mTOR%20Signaling%20Pathway%20in%20Human%20Prostate%20Cancer%20PC%E2%80%903%20Cells&amp;author=S.%20Qian&amp;author=H.%20Fang&amp;author=L.%20Zheng&amp;author=M.%20Liu&amp;volume=35&amp;issue=1&amp;publication_year=2021&amp;pages=e22611&amp;pmid=32905641&amp;doi=10.1002/jbt.22611&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0017">
<span class="label">17.</span><cite>
Russo M., Spagnuolo C., Tedesco I., and Russo G. L., “Phytochemicals in Cancer Prevention and Therapy: Truth or Dare?,” Toxins (Basel)
2, no. 4 (2010): 517–551, 10.3390/toxins2040517.
</cite> [<a href="https://doi.org/10.3390/toxins2040517" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3153217/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22069598/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Toxins%20(Basel)&amp;title=Phytochemicals%20in%20Cancer%20Prevention%20and%20Therapy:%20Truth%20or%20Dare?&amp;author=M.%20Russo&amp;author=C.%20Spagnuolo&amp;author=I.%20Tedesco&amp;author=G.%20L.%20Russo&amp;volume=2&amp;issue=4&amp;publication_year=2010&amp;pages=517-551&amp;pmid=22069598&amp;doi=10.3390/toxins2040517&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0018">
<span class="label">18.</span><cite>
Rizeq B., Gupta I., Ilesanmi J., AlSafran M., Rahman M. M., and Ouhtit A., “The Power of Phytochemicals Combination in Cancer Chemoprevention,” Journal of Cancer
11, no. 15 (2020): 4521–4533, 10.7150/jca.34374.
</cite> [<a href="https://doi.org/10.7150/jca.34374" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7255361/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32489469/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cancer&amp;title=The%20Power%20of%20Phytochemicals%20Combination%20in%20Cancer%20Chemoprevention&amp;author=B.%20Rizeq&amp;author=I.%20Gupta&amp;author=J.%20Ilesanmi&amp;author=M.%20AlSafran&amp;author=M.%20M.%20Rahman&amp;volume=11&amp;issue=15&amp;publication_year=2020&amp;pages=4521-4533&amp;pmid=32489469&amp;doi=10.7150/jca.34374&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0019">
<span class="label">19.</span><cite>
Rodriguez S., Skeet K., Mehmetoglu‐Gurbuz T., et al., “Phytochemicals as an Alternative or Integrative Option, in Conjunction With Conventional Treatments for Hepatocellular Carcinoma,” Cancers (Basel)
13, no. 22 (2021): 5753, 10.3390/cancers13225753.
</cite> [<a href="https://doi.org/10.3390/cancers13225753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8616323/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34830907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Phytochemicals%20as%20an%20Alternative%20or%20Integrative%20Option,%20in%20Conjunction%20With%20Conventional%20Treatments%20for%20Hepatocellular%20Carcinoma&amp;author=S.%20Rodriguez&amp;author=K.%20Skeet&amp;author=T.%20Mehmetoglu%E2%80%90Gurbuz&amp;volume=13&amp;issue=22&amp;publication_year=2021&amp;pages=5753&amp;pmid=34830907&amp;doi=10.3390/cancers13225753&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0020">
<span class="label">20.</span><cite>
Smalley K. S., “Understanding Melanoma Signaling Networks as the Basis for Molecular Targeted Therapy,” Journal of Investigative Dermatology
130, no. 1 (2010): 28–37, 10.1038/jid.2009.177.
</cite> [<a href="https://doi.org/10.1038/jid.2009.177" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19571822/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Investigative%20Dermatology&amp;title=Understanding%20Melanoma%20Signaling%20Networks%20as%20the%20Basis%20for%20Molecular%20Targeted%20Therapy&amp;author=K.%20S.%20Smalley&amp;volume=130&amp;issue=1&amp;publication_year=2010&amp;pages=28-37&amp;pmid=19571822&amp;doi=10.1038/jid.2009.177&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0021">
<span class="label">21.</span><cite>
Urs S., “B16‐F10: A Murine Melanoma Model,”
2019, <a href="https://drugdevelopment.labcorp.com/industry-solutions/oncology/preclinical/tumor-spotlights/b16-f10-a-murine-melanoma-model.html" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://drugdevelopment.labcorp.com/industry‐solutions/oncology/preclinical/tumor‐spotlights/b16‐f10‐a‐murine‐melanoma‐model.html</a>.</cite>
</li>
<li id="cep70059-bib-0022">
<span class="label">22.</span><cite>
Wilson V. G., “Growth and Differentiation of HaCaT Keratinocytes,” Methods in Molecular Biology
1195 (2014): 33–41, 10.1007/7651_2013_42.
</cite> [<a href="https://doi.org/10.1007/7651_2013_42" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24155234/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Methods%20in%20Molecular%20Biology&amp;title=Growth%20and%20Differentiation%20of%20HaCaT%20Keratinocytes&amp;author=V.%20G.%20Wilson&amp;volume=1195&amp;publication_year=2014&amp;pages=33-41&amp;pmid=24155234&amp;doi=10.1007/7651_2013_42&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0023">
<span class="label">23.</span><cite>
Scholtz W. and Mabeta P., “Sunitinib Malate Inhibits Hemangioma Cell Growth and Migration by Suppressing Focal Adhesion Kinase Signaling,” Journal of Applied Biomedicine
18, no. 4 (2020): 143–151, 10.32725/jab.2020.019.
</cite> [<a href="https://doi.org/10.32725/jab.2020.019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34907767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Applied%20Biomedicine&amp;title=Sunitinib%20Malate%20Inhibits%20Hemangioma%20Cell%20Growth%20and%20Migration%20by%20Suppressing%20Focal%20Adhesion%20Kinase%20Signaling&amp;author=W.%20Scholtz&amp;author=P.%20Mabeta&amp;volume=18&amp;issue=4&amp;publication_year=2020&amp;pages=143-151&amp;pmid=34907767&amp;doi=10.32725/jab.2020.019&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0024">
<span class="label">24.</span><cite>
Kallas A., Pook M., Maimets M., Zimmermann K., and Maimets T., “Nocodazole Treatment Decreases Expression of Pluripotency Markers Nanog and Oct4 in Human Embryonic Stem Cells,” PLoS One
6, no. 4 (2011): e19114, 10.1371/journal.pone.0019114.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0019114" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3084750/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21559451/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=Nocodazole%20Treatment%20Decreases%20Expression%20of%20Pluripotency%20Markers%20Nanog%20and%20Oct4%20in%20Human%20Embryonic%20Stem%20Cells&amp;author=A.%20Kallas&amp;author=M.%20Pook&amp;author=M.%20Maimets&amp;author=K.%20Zimmermann&amp;author=T.%20Maimets&amp;volume=6&amp;issue=4&amp;publication_year=2011&amp;pages=e19114&amp;pmid=21559451&amp;doi=10.1371/journal.pone.0019114&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0025">
<span class="label">25.</span><cite>
Zhao L., Au J. L., and Wientjes M. G., “Comparison of Methods for Evaluating Drug‐Drug Interaction,” Frontiers in Bioscience (Elite Edition)
2, no. 1 (2010): 241–249, 10.2741/e86.
</cite> [<a href="https://doi.org/10.2741/e86" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2885905/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20036874/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Frontiers%20in%20Bioscience%20(Elite%20Edition)&amp;title=Comparison%20of%20Methods%20for%20Evaluating%20Drug%E2%80%90Drug%20Interaction&amp;author=L.%20Zhao&amp;author=J.%20L.%20Au&amp;author=M.%20G.%20Wientjes&amp;volume=2&amp;issue=1&amp;publication_year=2010&amp;pages=241-249&amp;pmid=20036874&amp;doi=10.2741/e86&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0026">
<span class="label">26.</span><cite>
Kumar P., Yadav N., Chaudhary B., et al., “Promises of Phytochemical Based Nano Drug Delivery Systems in the Management of Cancer,” Chemico‐Biological Interactions
351 (2022): 109745, 10.1016/j.cbi.2021.109745.
</cite> [<a href="https://doi.org/10.1016/j.cbi.2021.109745" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34774839/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Chemico%E2%80%90Biological%20Interactions&amp;title=Promises%20of%20Phytochemical%20Based%20Nano%20Drug%20Delivery%20Systems%20in%20the%20Management%20of%20Cancer&amp;author=P.%20Kumar&amp;author=N.%20Yadav&amp;author=B.%20Chaudhary&amp;volume=351&amp;publication_year=2022&amp;pages=109745&amp;pmid=34774839&amp;doi=10.1016/j.cbi.2021.109745&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0027">
<span class="label">27.</span><cite>
Iqbal J., Abbasi B. A., Ahmad R., et al., “Potential Phytochemicals in the Fight Against Skin Cancer: Current Landscape and Future Perspectives,” Biomedicine &amp; Pharmacotherapy
109 (2019): 1381–1393, 10.1016/j.biopha.2018.10.107.
</cite> [<a href="https://doi.org/10.1016/j.biopha.2018.10.107" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30551389/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biomedicine%20&amp;%20Pharmacotherapy&amp;title=Potential%20Phytochemicals%20in%20the%20Fight%20Against%20Skin%20Cancer:%20Current%20Landscape%20and%20Future%20Perspectives&amp;author=J.%20Iqbal&amp;author=B.%20A.%20Abbasi&amp;author=R.%20Ahmad&amp;volume=109&amp;publication_year=2019&amp;pages=1381-1393&amp;pmid=30551389&amp;doi=10.1016/j.biopha.2018.10.107&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0028">
<span class="label">28.</span><cite>
Chu L. W., Chen J. Y., Chen Y. W., Hsieh S., and Kung M. L., “Phytoconstituent‐Derived Zingerone Nanoparticles Disrupt the Cell Adhesion Mechanism and Suppress Cell Motility in Melanoma B16F10 Cells,” Journal of Biotechnology
392 (2024): 48–58, 10.1016/j.jbiotec.2024.06.015.
</cite> [<a href="https://doi.org/10.1016/j.jbiotec.2024.06.015" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38906221/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biotechnology&amp;title=Phytoconstituent%E2%80%90Derived%20Zingerone%20Nanoparticles%20Disrupt%20the%20Cell%20Adhesion%20Mechanism%20and%20Suppress%20Cell%20Motility%20in%20Melanoma%20B16F10%20Cells&amp;author=L.%20W.%20Chu&amp;author=J.%20Y.%20Chen&amp;author=Y.%20W.%20Chen&amp;author=S.%20Hsieh&amp;author=M.%20L.%20Kung&amp;volume=392&amp;publication_year=2024&amp;pages=48-58&amp;pmid=38906221&amp;doi=10.1016/j.jbiotec.2024.06.015&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0029">
<span class="label">29.</span><cite>
Park J. H., Shin Y. J., Riew T. R., and Lee M. Y., “The Indolinone MAZ51 Induces Cell Rounding and G2/M Cell Cycle Arrest in Glioma Cells Without the Inhibition of VEGFR‐3 Phosphorylation: Involvement of the RhoA and Akt/GSK3β Signaling Pathways,” PLoS One
9, no. 9 (2014): e109055, 10.1371/journal.pone.0109055.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0109055" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4182637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25268128/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20One&amp;title=The%20Indolinone%20MAZ51%20Induces%20Cell%20Rounding%20and%20G2/M%20Cell%20Cycle%20Arrest%20in%20Glioma%20Cells%20Without%20the%20Inhibition%20of%20VEGFR%E2%80%903%20Phosphorylation:%20Involvement%20of%20the%20RhoA%20and%20Akt/GSK3%CE%B2%20Signaling%20Pathways&amp;author=J.%20H.%20Park&amp;author=Y.%20J.%20Shin&amp;author=T.%20R.%20Riew&amp;author=M.%20Y.%20Lee&amp;volume=9&amp;issue=9&amp;publication_year=2014&amp;pages=e109055&amp;pmid=25268128&amp;doi=10.1371/journal.pone.0109055&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0030">
<span class="label">30.</span><cite>
Hlophe Y. N. and Joubert A. M., “Vascular Endothelial Growth Factor‐C in Activating Vascular Endothelial Growth Factor Receptor‐3 and Chemokine Receptor‐4 in Melanoma Adhesion,” Journal of Cellular and Molecular Medicine
26, no. 23 (2022): 5743–5754, 10.1111/jcmm.17571.
</cite> [<a href="https://doi.org/10.1111/jcmm.17571" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9716217/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36398426/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Cellular%20and%20Molecular%20Medicine&amp;title=Vascular%20Endothelial%20Growth%20Factor%E2%80%90C%20in%20Activating%20Vascular%20Endothelial%20Growth%20Factor%20Receptor%E2%80%903%20and%20Chemokine%20Receptor%E2%80%904%20in%20Melanoma%20Adhesion&amp;author=Y.%20N.%20Hlophe&amp;author=A.%20M.%20Joubert&amp;volume=26&amp;issue=23&amp;publication_year=2022&amp;pages=5743-5754&amp;pmid=36398426&amp;doi=10.1111/jcmm.17571&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0031">
<span class="label">31.</span><cite>
Kung M.‐L., Huang S.‐T., Tsai K.‐W., Chu T.‐H., and Hsieh S., “Nanosized Zingerone‐Triggered Anti‐Angiogenesis Contributes to Tumor Suppression in Human Hepatocellular Carcinoma,” Colloids and Surfaces A: Physicochemical and Engineering Aspects
658 (2023): 130697.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Colloids%20and%20Surfaces%20A:%20Physicochemical%20and%20Engineering%20Aspects&amp;title=Nanosized%20Zingerone%E2%80%90Triggered%20Anti%E2%80%90Angiogenesis%20Contributes%20to%20Tumor%20Suppression%20in%20Human%20Hepatocellular%20Carcinoma&amp;author=M.%E2%80%90L.%20Kung&amp;author=S.%E2%80%90T.%20Huang&amp;author=K.%E2%80%90W.%20Tsai&amp;author=T.%E2%80%90H.%20Chu&amp;author=S.%20Hsieh&amp;volume=658&amp;publication_year=2023&amp;pages=130697&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0032">
<span class="label">32.</span><cite>
Chan W. J., Adiwidjaja J., McLachlan A. J., Boddy A. V., and Harnett J. E., “Interactions Between Natural Products and Cancer Treatments: Underlying Mechanisms and Clinical Importance,” Cancer Chemotherapy and Pharmacology
91, no. 2 (2023): 103–119, 10.1007/s00280-023-04504-z.
</cite> [<a href="https://doi.org/10.1007/s00280-023-04504-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9905199/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36707434/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Chemotherapy%20and%20Pharmacology&amp;title=Interactions%20Between%20Natural%20Products%20and%20Cancer%20Treatments:%20Underlying%20Mechanisms%20and%20Clinical%20Importance&amp;author=W.%20J.%20Chan&amp;author=J.%20Adiwidjaja&amp;author=A.%20J.%20McLachlan&amp;author=A.%20V.%20Boddy&amp;author=J.%20E.%20Harnett&amp;volume=91&amp;issue=2&amp;publication_year=2023&amp;pages=103-119&amp;pmid=36707434&amp;doi=10.1007/s00280-023-04504-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0033">
<span class="label">33.</span><cite>
Xu Z., “Inhibitory Effects of Zingerone Combined With Sorafenib on Migration and Invasion of Human Liver Cancer HepG2 Cells,” Journal of Jilin University (Medicine Edition)
45 (2019): 228–233.</cite> [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Jilin%20University%20(Medicine%20Edition)&amp;title=Inhibitory%20Effects%20of%20Zingerone%20Combined%20With%20Sorafenib%20on%20Migration%20and%20Invasion%20of%20Human%20Liver%20Cancer%20HepG2%20Cells&amp;author=Z.%20Xu&amp;volume=45&amp;publication_year=2019&amp;pages=228-233&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="cep70059-bib-0034">
<span class="label">34.</span><cite>
Cao X., Chen C. W., Yin K., et al., “Zingerone Facilitates Apoptosis in Triple Negative Breast Cancer Cells by Inducing Autophagy,” Journal of Biochemical and Molecular Toxicology
38, no. 12 (2024): e70074, 10.1002/jbt.70074.
</cite> [<a href="https://doi.org/10.1002/jbt.70074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39620438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Journal%20of%20Biochemical%20and%20Molecular%20Toxicology&amp;title=Zingerone%20Facilitates%20Apoptosis%20in%20Triple%20Negative%20Breast%20Cancer%20Cells%20by%20Inducing%20Autophagy&amp;author=X.%20Cao&amp;author=C.%20W.%20Chen&amp;author=K.%20Yin&amp;volume=38&amp;issue=12&amp;publication_year=2024&amp;pages=e70074&amp;pmid=39620438&amp;doi=10.1002/jbt.70074&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Clinical and Experimental Pharmacology &amp; Physiology are provided here courtesy of <strong>Wiley</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1111/1440-1681.70059"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/CEP-52-0.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (3.2 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12283137/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12283137/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12283137%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12283137/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12283137/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12283137/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40695356/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12283137/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40695356/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12283137/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12283137/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="hKYerNFJ8GeHsDMx4iMAR5uSFFX89IoNgZIKq4xf0SxkkTZj0QfLKnnPiMAASXso">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Web Policies

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    FOIA

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS Vulnerability Disclosure

    
</a>

                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Help

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Accessibility

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            








<a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    Careers

    
</a>

                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NLM

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
    

    NIH

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    HHS

    
</a>

                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            








<a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
    

    USA.gov

    
</a>

                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-370d5dd6.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-917ba005.js"></script>
    
        <script type="module" crossorigin="" src="/static/assets/math-d9849939.js"></script>
    
    

    </body>
</html>
